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Pneumonia is responsible for an estimated 44% of deaths in children under 5 
years of age in the Himalayan communities of the Northern Areas, Pakistan. The 
objectives of the three papers included in this thesis were to 1) determine the incidence of 
pneumonia in children using the World Health Organization Integrated Management of 
Childhood Illness (IMCI) criteria; 2) evaluate the impact of intensive follow-up training 
for Community Health Workers (CHWs) on pneumonia recognition and referral; and 3) 
compare health center staff classification of pneumonia based on IMCI criteria with 
evaluation by pediatricians. 
Children 2-35 months were followed at home every two weeks by CHWs and 
surveillance was simultaneously established at 15 health centers for pneumonia. CHW 
performance was evaluated at six-weekly intervals using pre- and post-tests, by 
measuring the proportion of children with severe disease they referred correctly to health 
centers, and by comparing the incidence rates for pneumonia among children in their 
coverage area. Misclassification of disease was measured by determining overall 
agreement between health center staff classification of disease with a pediatrician’s 
evaluation at a referral hospital in Gilgit. 
The incidence rate was 29.9 per 100 child years of observation (CYO) for 
pneumonia and 8.1 per 100 CYO for severe pneumonia. The proportion of children that 
were correctly referred for severe disease by CHWs increased from zero at baseline to 
above 80% over one year. Significant improvements were reported between the pre- and 
post-test results of CHW in all 10 tests conducted (paired sample t-test p-value <0.001). 
Using the pediatrician’s diagnosis as reference, health center staff correctly classified 125 
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(74.9%) of the children with severe pneumonia, and failed to identify 42 (25.1%) of 
children with the disease. Staff incorrectly labeled 328 (72.4%) children from the 453 
they classified as children with severe pneumonia. Fewer children with pneumonia were 
missed (11.5%) or labeled incorrectly (2.8%).  
The pneumonia incidence rates in this Himalayan region are among the highest 
reported, even after adjustments for over-diagnosis of severe pneumonia. Sustained 
improvements in pneumonia referral were achieved following intensive training for 
CHWs.  These findings warrant consideration of new intervention strategies in this 
region. 
 
Advisor:    Neal Halsey 
Committee of Final Readers:  Jonathan Weiner (Chair), Lawrence Moulton 





 This dissertation is the culmination of six years of work I have coordinated 
and conducted with a dedicated team of researchers in Baltimore, Gilgit and Karachi. The 
study was initially conceptualized over a lunch discussion with my advisor in the spring 
of 1999 and it took two years of preparation before we finally opened our office in Gilgit. 
Much of that time was spent writing the protocol, visiting Gilgit and Karachi many times 
to lay the groundwork for collaboration and expanding the core research team. All of this, 
of course, required funding.  
 In early 2000, we successfully procured funding for protocol development and 
site visits from Smith Kline Beecham, a company that was developing a new 
pneumococcal vaccine. Pasteur Mèrieux Foundation provided additional funds later that 
same year, allowing us to establish the field site, enroll children and begin disease 
surveillance in 2001. Aventis Pasteur awarded funds in early 2002 to plan for a 
pneumococcal vaccine trial at an expanded site in the Northern Areas and an urban site in 
Karachi. By June of 2002, however, the security situation had deteriorated in neighboring 
Afghanistan and spilled over to Pakistan. Both vaccine manufacturers elected to 
withdraw support and focus on other areas for field studies that appeared to be more 
secure for foreign personnel. Lack of continuing financial support resulted in stopping 
enrollment and follow-up on December 31, 2002, although the core coordination and data 
management team continued working until August 2003.  Data analysis, dissertation 
writing and the development of a new urban site for cohort studies in Karachi have 
consumed the past two years. In 2005, the Global Alliance for Vaccines and 
Immunization (GAVI) Accelerated Development and Introduction Plan for 
 
 v
pneumococcal vaccines (PneumoADIP) selected the Karachi urban site for development 
for potential multi-country vaccine trials in Asia. Whatever the outcome of the current 
effort may be, a career spent researching new vaccines and figuring out ways to speed up 
their introduction to countries like Pakistan will continue to remain both challenging and 
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Acute Lower Respiratory Tract Infections 
Acute lower respiratory infections (ALRI) are a group of illnesses transmitted 
through aerosolized droplets. ALRI occur distal to the epiglottis and include 
laryngitis, tracheitis, bronchitis, bronchiolitis and pneumonia. The common etiologic 
agents of viral pneumonia include the respiratory syncytial virus (RSV), influenza A 
and B viruses, parainfluenza virus and adenoviruses.1 While most ALRI are non-life 
threatening viral infections, some such as RSV and influenza A and B viruses can 
result in severe disease and death.2 The frequency of viral respiratory infections is 
highest during infancy and between ages 1-4 years.3 Viral infections also hinder 
ciliary action in the bronchioles, which may predispose to super-infection with 
bacterial pathogens. Pneumonia is the most serious manifestation of ALRI, with 
Streptococcus pneumoniae and Haemophilus influenzae type b (Hib) reported as the 
most common causes of bacterial pneumonia in children 2 months to 5 years of age.4 
 
Mortality from Pneumonia 
There were approximately 10.8 million global deaths among children less than 
5 years of age in the year 2000.5 Bryce and colleagues estimate that 19% of global 
deaths in children less than 5 years during 2000-2003 were attributable to 
pneumonia.6  
Pakistan was fourth in a ranking of countries by the total number of under-5 
deaths, with an estimated 565,000 deaths in the year 2000.7 Good data on the 
proportion of childhood deaths that are attributable to pneumonia in Pakistan are 
limited. The cause-specific mortality rate from pneumonia in children less than 5 
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years of age was reported to be 14 deaths per 1,000 children per year in Abbotabad 
(altitude 1,200 feet) by Khan and colleagues in 1987 prior to interventions. 8 Marsh 
and colleagues used verbal autopsy methods to classify 66 deaths in children less than 
5 years from 1988-1991 in a village situated near 5,000 feet in the Northern Areas of 
Pakistan.9 They estimated that 44% of all deaths in children under 5 years were due to 
pneumonia.  Verbal autopsy of all under-5 deaths was later incorporated into the Aga 
Khan Health Service Pakistan (AKHSP) program in the Northern Areas, where 
pneumonia remains the leading cause of death in young children, causing 33% of all 
deaths in infants and 37% of all deaths in children 1 to 4 years in these areas in 
1999.10 
 
Incidence of Pneumonia in Pakistan 
In a 1984 study designed to characterize the determinants of child health in 
rural and urban settings in Lahore, a cohort of 1,476 newborns was followed every 4 
weeks at home until 24 months of age.11 The study design had some limitations with 
regard to respiratory tract infections; the diagnosis of disease was based on a month’s 
recall of the main signs and symptoms of the illness reported and if these were 
recurring between two home visits they were reported as a single episode. The 
pneumonia incidence rates reported were 22 per 100 CYO, indicating that pneumonia 
was a major contributor to morbidity and, potentially, mortality during the first two 
years of life in this population.12,13 These data remain the only community based 
incidence rates for pneumonia from Pakistan reported in peer-reviewed journals.  
Rasmussen and colleagues established community based surveillance for 
pneumonia in Oshikhandass village (located at approximately 5,000 feet in the 
Northern Areas) between December 1992 and June 1996. They reported 990 episodes 
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of pneumonia (based on WHO ARI criteria) in 1,800 children followed from 2-59 
months of age and estimated the pneumonia incidence to be 44 per 100 child years of 
observation.14 The very high incidence rate reported and the fact that the data are from 
a single village do raise questions about their generalizability. 
 
Risk Factors Associated with Community-Acquired Pneumonia in Children 
Pneumonia incidence is most strongly and consistently associated with young 
age, with the highest reported rates in children between 2-6 months old.2,3 Other 
factors associated with pneumonia include male gender,3 malnutrition,15,16 
micronutrient deficiency,17,18 low immunization coverage,19,20 low household 
income,21,17 overcrowding,22 poor breastfeeding practices,23,24 and exposure to indoor 
air pollution.25,26 
The higher incidence rate of pneumonia in children living at high altitudes is 
well established from studies in the Peruvian Andes and Papua New 
Guinea.27,28,29Much of the research conducted on the physiological responses of 
children at high altitude has come from populations living above 10,000 feet in the 
Peruvian Andes. Steinhoff and colleagues showed that it takes newborns between 3-4 
years to adapt physiologically to high altitudes, which include compensating by 
increased ventilation, cardiac output, vital capacity and a shift in the oxy-hemoglobin 
affinity curve.30 The degree to which these findings from the Andes in populations 
living over 10,000 feet may apply to most children in Punial and Ishkoman who live 






Integrated Management of Childhood Illness (IMCI) 
The World Health Organization (WHO) Integrated Management of Childhood 
Illness (IMCI) strategy has been endorsed by the Government of Pakistan as an 
effective tool to reduce early childhood morbidity and mortality from pneumonia, 
diarrhea, malnutrition, measles and malaria.31 The strategy aims to improve the 
management of common childhood illnesses by focusing upon 1) health systems 
development, 2) case management at first-level health care facility, and 3) community 
and family knowledge and practices.  
Health system development takes place by identifying and addressing 
weaknesses in drug availability, planning and implementation, and health information 
systems.32,33 
The guidelines for case management by health center staff are generic and 
have to be adapted by a national expert committee for use in individual countries.34 
The methods proposed to train health center staff include a standard 11-day training 
course that comprises supervised clinical assessments on patients and classroom 
teaching. A follow-up visit to each health center staff is conducted within 4 to 6 
weeks of training. 
 The strategy and plan for the implementation of the third element of IMCI 
involving community health workers are being considered in Pakistan. 
 
Pneumonia and Severe Pneumonia Classification under IMCI 
 Pneumonia and severe pneumonia are mutually exclusive classifications under 
IMCI. (See Table 1) A pneumonia classification is made in a child 2-59 months of age 
with a history of cough or difficulty breathing in the presence of a respiratory rate that 
is higher than the cut-off established by WHO for infants and young children. A 
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severe pneumonia classification is made in a child 2-59 months of age with a history 
of cough or difficulty breathing and any one of the following: chest indrawing, 
stridor, or any general danger sign. General danger signs include lethargy and 
unconsciousness, persistent vomiting, convulsions and inability to feed or drink. An 
increased respiratory rate above the WHO cut-off values is not required to make a 
classification of severe pneumonia. 
 
National Health Worker Program 
The government-run National Health Worker Program enlists village-based, 
community health workers (CHWs) to make monthly household visits and provide 
primary care services at home. CHWs are trained to screen children for signs and 
symptoms that require referral and to treat simple illnesses according to WHO 
guidelines. Sick children are preferentially referred to government health centers. The 
guidelines of the national program assign approximately 1,000 persons to a CHW, but 
due to the greater distances between houses and the difficult terrain involved in the 
Northern Areas, CHWs are assigned fewer families (between 400-600 persons). 
 
The Northern Areas of Pakistan 
The Northern Areas of Pakistan consist of five districts (Ghizer, Gilgit, 
Diamer, Skardu and Ganche) and form the western limit of the Himalayas that 
separate South Asia from China (Map). The confluence of four mountain ranges 
(Karakorum, Hindukush, Pamirs, and the Tian Shan) makes this one of the most 
geologically active regions of the earth. The Northern Areas is ethnically and 
linguistically diverse, with an estimated 2001 population of 1.2 million.35 Aside from 
Gilgit and Skardu that serve as administrative and urban centers for the region, the 
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Northern Areas consists of widely dispersed, small, rural agricultural communities 
located mostly between 5,500 to 8,500 feet. 
 
Some summer pastures and residences are located above 10,000 feet, but are 
only occupied for 2-3 months of the year. The region has extreme temperature 
variations, ranging from 42° Celsius in June to -15° Celsius in January. 
 
Health Care in the Northern Areas 
The Government and the Aga Khan Health Service, Pakistan (AKHSP) jointly 
provide health care in the Northern Areas. The government structure is functional in 
all the districts while the AKHSP provides medical services in the western districts of 
Ghizer and Gilgit.  
The AKHSP primary health care (PHC) program was initiated in the late 
1980s and is divided into modular units along the major valley systems of districts 
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Ghizer and Gilgit. There were 7 PHC modules in 2001, each with a director 
headquartered within the valley. Each module director worked closely with the 
General Manager in Gilgit and local health boards. The infant mortality rate (IMR) in 
AKHSP program areas were 37 per 1000 live births and the under 5 mortality rate 
(U5MR) were 50 per 1000 live births in 2000.9  
 The Government of Pakistan health system is a relatively recent but more 
extensive health service. To increase access to health care, the government undertook 
a national initiative called the National Health Worker (NHW) Program in 1995. 
Under this initiative, community health workers (CHWs) make household visits every 
month and provide free basic medical services at home. They are trained to treat 
febrile, acute respiratory and diarrheal illnesses and some skin diseases according to 
WHO guidelines. They are also trained to prescribe antibiotic therapy (cotrimoxazole, 
oral ampicillin and oral amoxicillin) for these illnesses when necessary. The role of 
CHWs is limited to conducting household visits and to using their personal homes as 
a ‘health house’ for the community at large to seek very basic medical attention. 
CHWs do not see patients at health facilities, although they are supervised in their 
household visits by health center staff. 
CHWs refer patients to their corresponding government health centers or 
Basic Health Unit (BHU), usually staffed by a physician in this region. Some BHUs 
have a small laboratory with the ability to do a blood count. Patients seen at BHUs 
can be referred to a higher level health facility also know as a Civil Hospital with in-
patient, X-ray and laboratory facilities that is usually staffed by 1-2 physicians and 2-
3 nurses. Tertiary care health facilities in the government system are referred to as 
District Head Quarter (DHQ) Hospital. In practical terms, facilities are likely to vary 
and many designated Civil Hospitals will be functioning with the facilities of a BHU.  
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In Pakistan, a common type of female health center staff is traditionally called 
Lady Health Visitors (LHVs). LHVs are trained for one year each in nursing and 
midwifery. AKHSP health centers are staffed by 2 LHVs trained to diagnose common 
medical conditions and prescribe medications (including antibiotics) using established 
WHO Integrated Management of Childhood Illness (IMCI) guidelines. They work 
with the government Expanded Programme on Immunizations (EPI) office to provide 
community and facility-based immunization services throughout the AKHSP 
coverage area. AKHSP adheres to the national schedule for EPI (6, 10 and 14 weeks). 
Newborns receive OPV and BCG at birth. OPV and DPT are administered at 6, 10, 
and 14 weeks and measles at 9 months of age. In 2000, 71% of children resident in 
the AKHSP program areas had received all EPI recommended vaccines by one year 
of age. This decline from 93% in 1997 resulted from the inclusion of the new Gilgit 
module that had a poorly immunized population, and not due to decline in coverage in 
other areas. In addition to immunization services, the staff also conduct health center 
and community based antenatal care clinics and supervise the work of CHWs. 
Medical emergencies are referred to secondary or tertiary care facilities. 
Because of the relative remoteness of the region in general and some villages in 
particular, village based volunteer local health boards have organized a system in 
which 4-wheel drive vehicles are available on demand for medical emergencies at a 
number of points along the valleys. The cost of using the system can vary from 200-
500 rupees ($3-8) for a one-way trip. Notwithstanding the expense incurred by the 





Structure of Dissertation 
 This dissertation is structured in the form of three independent but inter-
related papers.  
 Paper 1 is entitled “Incidence of Pneumonia among Children 2-35 Months 
of Age Living at High Altitudes in Pakistan”. This study involved enrolling children 
at home and tracking their visits to health facilities to identify children with 
pneumonia based on IMCI criteria.  
 Paper 2 is entitled “Intensive follow-up training of Community Health 
Workers on Pneumonia Recognition and Referral in Children less than 3 years in 
Pakistan”.  Community Health Workers (CHWs) were trained at 6-weekly intervals 
over 14 months and assessed based on pre- and post-test scores on each training day, 
the appropriate referral  
 Paper 3 is entitled “Comparison of health center staff classification of 
pneumonia based on WHO IMCI criteria with evaluation by pediatricians in an 
outpatient setting in Gilgit, Pakistan” Health center staff at the tertiary care referral 
facility in Gilgit (DHQ Hospital) screened children presenting to an out-patient 
pediatric department for signs and symptoms of pneumonia. The pediatricians’ 
evaluations were used as a gold standard for comparison with the health center staff 
classification of disease.  
 The papers are followed by a conclusion that states the key findings of 
these studies and constructs a case for a probe vaccine trial in the Northern Areas. The 
Appendix includes the consent and survey forms, and methods for the proposed 
vaccine trial. 
 A timeline for some of the major field activities is shown in Figure 1. 
 
 10
Figure 1. Timeline for major field activities in the Northern Areas of Pakistan, April 2001- December 2002. 
 2001 2002 
 7 8 9 10 11 12 1 2 3 4 5 6 7 8 9 10 11 12 
Punial and Ishkoman                   
IMCI Training for CHWs                   
Baseline                       
Follow-up                                 
                   
Home-based Enrollment                   
Baseline (<24 months)                       
Newborns                                     
                   
Health Center 
Surveillance                   
Phased In                     
Fully Established                                 
                   
Gilgit                    
DHQ Hospital Study                                     
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Pneumonia is the leading cause of death among Pakistani children less than 5 
years of age living in the Himalayan regions. The purpose of this study was to 
determine the incidence of IMCI classified pneumonia and severe pneumonia among 
these children. 
Community Health Workers (CHWs) in Punial and Ishkoman enrolled 
children at home and conducted follow-up visits every two weeks. Health center staff 
based at 15 health facilities in Punial and Ishkoman used Integrated Management of 
Childhood Illness (IMCI) criteria to screen all sick children and identify those 2-35 
months of age with cough or difficulty breathing and any one or more of fast 
breathing, chest indrawing, stridor or general danger signs.  
CHWs enrolled 5,204 eligible children at home over a 14 month period. 
Health center staff identified 1,397 cases of pneumonia and 377 of severe pneumonia 
in children 2-35 months of age among enrolled children. The reported incidence rates 
for pneumonia and severe pneumonia were 29.9 and 8.1 per 100 child years of 
observation (CYO), respectively. Younger age and living at higher altitude were 
associated with higher incidence rates for pneumonia and severe pneumonia.  
Pneumonia incidence rates in the Northern Areas of Pakistan are much higher 
than rates reported at lower altitudes and in other developing countries. Efforts are 
needed to determine the etiology of pneumonia in these communities, including the 
use of ‘probe’ vaccine trials to evaluate the proportion of disease that could be 







Pneumonia is a leading cause of childhood death in countries with high under-
5 mortality rates and continues to be the second leading cause of death among 
Pakistani children less than 5 years of age.36,37 The cause-specific mortality rate from 
pneumonia in children less than 5 years of age was reported to be 14 deaths per 1000 
children per year in Abbotabad (altitude 1,200 feet) by Khan and colleagues38 in 1987 
prior to interventions. Marsh and colleagues,39 using verbal autopsy methods in a 
village situated at just over 5,000 feet in the Northern Areas of Pakistan reported that 
44% of all deaths in children under 5 were due to pneumonia.  Verbal autopsy 
methods have been used by the Aga Khan Health Service Pakistan (AKHSP) in the 
Northern Areas where pneumonia is the leading cause of death in young children, 
causing 33% of all deaths in infants and 37% of all deaths in children 1 to 4 years in 
these areas in recent years.40 
In a 1984 study in Lahore (altitude 400 feet above sea level), a cohort of 1,476 
newborns followed every 4 weeks at home revealed a pneumonia incidence rate of 22 
per 100 child years among infants.41 The study had some limitations. The diagnosis 
was based on a maternal recall of signs and symptoms, symptoms recurring between 
two home visits were reported as a single episode, and concurrent facility-based 
surveillance was not in place.42,43 These data remain the only published community 
based incidence rates for pneumonia from Pakistan. Unpublished studies conducted in 
Oshkindass during the 1990s indicate an incidence of 30 cases of pneumonia per 100 
child years of observation in children less than 5 years of age.44  
Pneumonia is the most serious manifestation of acute lower respiratory tract 
infections, with Streptococcus pneumoniae and Haemophilus influenzae type b (Hib) 
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reported as the most common causes of bacterial pneumonia in children 2 months to 5 
years of age.45 Studies describing risk factors for community-acquired childhood 
pneumonia in Pakistan are limited, but appear to be similar to factors identified in 
other developing countries.46 Between February and April 2000, Fatmi and White 
conducted a case control study at the major referral hospital in the Northern Areas 
(District Head Quarters Hospital, Gilgit), comparing 259 children with pneumonia  to 
187  children with ‘cough and cold’ as controls. Risk factors for pneumonia included 
lack of immunization, history of pneumonia, malnutrition, and younger age.47 
The World Health Organization’s (WHO) strategy for the Integrated 
Management of Childhood Illness (IMCI) has been endorsed by the Government of 
Pakistan as an effective tool to reduce early childhood morbidity and mortality from 
pneumonia, diarrhea, malnutrition, measles and malaria.48 The purpose of this study 
was to determine the incidence of IMCI classified pneumonia, severe pneumonia and 
very severe febrile disease in a cohort of children followed from 2 to 35 months of 





The Punial and Ishkoman valleys of the Northern Areas had an estimated 
population of 59,000 in 2001.49 Villages in Punial are situated within an altitude range 
of 5,500-6,499 feet and in Ishkoman between 6,500-8,499 feet, although two villages 
in Ishkoman are above 8,500 feet. The temperature ranges from 40° C in July to -15° 
C in January. A household commonly includes more than one generation of married 
couples and their children sharing a dwelling and kitchen. Wood fires are most 
 
 16
commonly employed for cooking and heating homes. Farming is the primary means 
of livelihood, although younger men are more likely to seek a career in the military or 
government. 
 Village-based organizations and volunteers working with the Aga Khan 
Development Network (AKDN) have brought about significant improvements in 
agricultural practices, literacy and health.50 The Aga Khan Health Service Pakistan 
(AKHSP) primary health care (PHC) program has reduced infant mortality rates 
(IMR) to below 40 per 1000 live births in its program areas. Eighty four percent of 
children are fully immunized by 1 year of age and over 60% of infants are exclusively 
breast fed till 4 months of age.51  However, 22% of infants and 24% of children 1-4 
years have grade 1 malnutrition. AKHSP had 5 PHC centers (staffed by two LHVs 
each) and one secondary health care (SHC) center in Punial-Ishkoman during 2001-
2002. The government health system in Punial-Ishkoman was more extensive, with 9 
PHC and 2 SHC centers. Four PHC and all SHC centers were staffed by physicians 
and paramedics.  Government centers charge a nominal fee relative to AKHSP 
centers, where cost-recovery is considered essential for sustainability. The 
government run National Health Worker Program enlists village-based, community 
health workers (CHWs) to make monthly household visits and provide primary care 
services at home. CHWs are trained to screen children for danger signs that require 
referral and to treat simple illnesses according to WHO guidelines. Sick children are 
preferentially referred to government centers. Due to the remoteness of the region 
village organizations ensure that 4-wheel drive vehicles are available for medical 




Study Design  
This was a longitudinal cohort study in which (1) all children 0-24 months of 
age were enrolled at baseline and (2) all newborns were enrolled from the baseline 
until the end of the study.  Children were followed by CHWs at home every two 
weeks, who referred sick children to health center staff. Health center staff screened 
sick children and identified those with pneumonia or severe pneumonia. 
 
Outcomes 
The primary outcomes were pneumonia and severe pneumonia as defined 
under the Integrated Management of Childhood Illness guidelines for children 2 
months to 5 years of age (Table 1). All primary outcomes were determined at health 
centers. Children under 2 months were not included in this analysis as IMCI 
guidelines do not have a separate classification for pneumonia or severe pneumonia 
for this age group 
  
Eligibility for Enrollment 
All children less than 24 months of age at the start of the study and all 




CHWs enrolled children less than 24 months of age at their homes between 
July 24, 2001 and October 31, 2001. All newborns were enrolled from July 24, 2001 
onwards until December 31, 2002. Enrolled children were given a unique 
identification number by incorporating a code based on the area, CHW, household 
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and mother. An ID card was provided to each mother with the names, gender, age and 
identification number of all of her enrolled children. Mothers were told to present this 
card to any health center they visited for a sick visit. 
 
Home Visits 
Enrolled children were visited at home every two weeks by the CHWs serving 
their area. During each home visit, information was recorded on whether the child 
was alive and present at home; the signs and symptoms of current illness, if any; the 
symptoms of past illness based on the care-provider’s two-week recall; and 
immunizations received. At the time of each visit, mothers were encouraged to seek 
care for their sick children based on IMCI counseling guidelines. Families were 
encouraged to have acutely ill children screened by local CHWs who decided on the 
need for treatment and referral using IMCI guidelines.  
 
Identification of Sick Children at Health Centers  
Surveillance for IMCI-classified pneumonia and severe pneumonia among 
children 2 to 35 months of age was phased in across health centers in Punial and 
Ishkoman over a two month period beginning September 1, 2001. Nineteen health 
centers participated in the study, including 12 government primary health care 
centers, 5 AKHSP primary health care centers, a commercially run private clinic and 
a charity-sponsored clinic in Ishkoman. Surveillance was stopped at 4 centers (three 
government first aid posts and the private clinic) in December of 2001 due to staff 
leave of absence or extremely low patient turn out. Surveillance at 15 health centers 
continued until December 31, 2002.  
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Health center staff screened all children between 2-35 months of age who 
presented to their center. Children with cough or difficulty breathing and one or more 
of fast breathing, chest indrawing, stridor, or general danger signs were further 
evaluated and classified according to IMCI guidelines. As the government IMCI 
strategy had not been implemented at the time of this study, physicians and health 
center staff used similar but older government guidelines based on the WHO Acute 
Respiratory Infections (ARI) Control Programme to treat or refer children with 
pneumonia or severe pneumonia. 
The unique identification number of each child was noted on the health facility 
visit form. If the attendant did not present the ID card given to mothers of all children 
enrolled at home, information on the mother and child was collected on a separate 
form (Red Card) to be sent for follow-up to the CHW assigned to the child’s village.  
 
IMCI Training 
Health care personnel in Punial and Ishkoman working at government, 
AKHSP or private centers and all government CHWs from the National Health 
Workers Program were trained to use WHO IMCI guidelines (see Paper 2).  Particular 
emphasis was placed on the recognition and management of pneumonia and the 
recognition and referral of severe pneumonia among children 2-59 months of age. 
Three medical officers and 8 LHVs at AKHSP facilities had been trained in the use of 
IMCI guidelines and received refresher training. Ninety-nine CHWs, 11 program 
supervisors, 8 medical officers and 17 paramedical staff in the government health 
system received IMCI training along with two paramedics in the private sector. All 
community and facility based staff were visited by a project LHV, nurse and medical 
officer at least every two weeks to review home visit schedules, data forms, IMCI 
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classification of disease and referral practices. Cases of pneumonia and severe 
pneumonia for this study were counted at health facilities. 
  
Statistical Methods 
The age-specific incidence of pneumonia and severe pneumonia was 
calculated by dividing the total number of cases identified at all participating health 
facilities by the months of observation contributed by children in 2 month age 
intervals. Incidence rate calculations were based upon the outcomes detected from 
November 1, 2001 when home based enrollment had been completed until December 
31, 2002. Associations between the incidence of disease and age, altitude, and number 
of other children in the household were explored using Poisson regression. 
The records of sick children enrolled at health centers were verified and cases 
meeting IMCI criteria were included in the analysis.  The months of observation 
contributed by individual children were calculated from the date of enrollment until 
the date the child 1) became 36 months of age, 2) was reported to have died or 3) 
migrated out of the surveillance area along with the mother.  Provision was made for 
those children who may have moved out of the surveillance area for shorter periods of 
time (including moving with the mother to summer-time pastures) by subtracting the 
weeks of observation the child was reported not to have been at home on 3 or more 
consecutive visits. 
Information collected at the time of home-based enrollment and on subsequent 
home visits was linked with the information collected at participating health facilities. 
If the child’s surveillance number was unavailable, additional information collected at 
the time of the facility visit permitted us to procure the surveillance identification 
number at a later date.  
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 Forms used at the site were optimized for scanning and optical character 
recognition using TELEform® 6 (Sunnyvale, CA) and Microsoft Access® 2000 was 
used for checking data integrity.  Data were analyzed using SPSS® version 11.5 for 
frequency analysis and cross-tabulation and STATA® version 8.0 (College Station, 
TX) for Poisson regression. 
 
IRB Approvals 
This study was approved by the institutional review boards (IRB) at the Johns 
Hopkins Bloomberg School of Public Health and the Aga Khan University. Written 





There were 5,204 children enrolled at home; 3,436 were children less than 24 
months of age at the start of surveillance, 1,685 were born during the surveillance 
period and 83 eligible children migrated into the area. There were 54,047 months 
(4,504 years) of observation contributed by enrolled children 2 to 35 months of age 
between November 1, 2001 and December 31, 2002.  
Health center staff at participating facilities reported 2,147 eligible cases of 
pneumonia, severe pneumonia and very severe febrile disease among the 5,204 
children enrolled. There were 1,790 (83%) cases correctly classified by health center 
staff (based on an internal consistency check of signs and symptoms recorded) and 
included 1,397 cases of pneumonia, 377 of severe pneumonia, and 16 of very severe 
febrile disease. The distribution of children with pneumonia presenting to health 
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facilities by altitude is shown in Table 2. The signs, symptoms and other observations 
reported with these IMCI classified illnesses are shown in Table 3. The seasonal 
distributions of pneumonia and severe pneumonia are shown in Figure 2. 
 A total of 1,348 episodes of pneumonia were reported among 949 children and 
347 episodes of severe pneumonia among 311 children by health center staff between 
November 1, 2001 and December 31, 2002, when home-based enrollment had been 
completed and surveillance was fully established at 15 health facilities. Two hundred 
and sixty two children (28%) with pneumonia and 24 children (8%) with severe 
pneumonia had multiple episodes of the disease. Thirty-eight episodes of pneumonia 
and four of severe pneumonia were reported among children who presented to health 
facilities twice within one month and in whom the duration of symptoms overlapped 
for the two visits.  
The annual community based incidence of pneumonia was 29.9 per 100 child 
years of observation (CYO) and 8.1 per 100 CYO for severe pneumonia among 
children 2 to 35 months of age in Punial-Ishkoman. The average incidence of 
pneumonia and severe pneumonia by altitude are shown in Table 2 and the incidence 
rates by age are shown in Figure 3. The incidence of pneumonia and severe 
pneumonia by age are shown in Table 4.  
Pneumonia incidence rate ratios were calculated in a Poisson regression using 
age, altitude, number of infants in a household, and gender as covariates (Table 5). 
Incidence rate ratios were highest at 6.63 in children 4- <5 months of age (p-
value<.001; 95% confidence limits 5.17, 8.49) in comparison to children in the 
reference age group (24-35 months). This ratio decreased for older children but 
remained significantly higher (p-value<.05) for all subsequent age groups in 
comparison to children 24-35 months of age. 
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The pneumonia incidence rate was 1.66 times higher (p<0.01; 1.45,1.89) in 
children living at 6,500-7,499 feet than children living at 5,500-6,499 feet, the 
reference group. The incidence rate ratio for children living at 7,500-8,499 was close 
to 1 and not significantly different than the reference group (Table 5). However, the 
incidence rate ratio was 0.15 for children living above 8,500 feet (p<0.01; 0.07,0.32) 
in comparison to the reference group. 
The incidence rate ratios (IRR) among children living in households with 1-2 
children less than less than 36 months of age (IRR 1.03; 95% confidence limits 0.91, 
1.17) and those with 3 or more children less than 36 months of age (IRD 0.90; 0.4, 
2.0) were not significantly different (p>0.05) than the ratio among those children 




The incidence rate of pneumonia and severe pneumonia combined (38 per 100 
child years of observation) among children 2 to 35 months of age living in this area is 
much higher than rates reported at lower altitudes in Pakistan and other settings 
(Table 6).  
Possible explanations for these high rates may include over-diagnosis by 
health workers, harsh winter seasons that entail spending long durations of time in 
overcrowded homes, heating and cooking by wood-fires, and increased baseline 
respiratory rates among infants and children living at high altitudes.  
 The classification of sick children made by facility based health workers were 
checked for internal consistency based upon the signs and symptoms recorded on the 
Health Facility Visit Form. (See Appendix) A household socioeconomic survey 
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conducted in 2002 in this area revealed an average of 9.5 persons (median 8, range 1-
37) per household and 2.7 rooms  per household (median 2, range 1-13).52 The mean 
number of persons per room was 3.5 (median 3.7, range <1-24). Almost all 
households (98%) used wood-stove (bukhari) fires for cooking and keeping the 
sleeping area warm throughout the year. Children living in households that had 3 or 
more other children less than 3 years of age residing in them had substantially higher 
rates of pneumonia than those living in households with no infants. This relationship 
was not seen for the number of children 2 years or older living in a household. While 
it is possible that exposure to nasopharyngeal pathogens (including Haemophilus 
influenzae type b and Streptococcus pneumoniae) may be higher per person on 
average in households with 3 or more children under 3 years living in the same 
household, this association was not observed in the Poisson regression. 
One limitation of this study was that regular, home-based enrollment was not 
possible in two small villages of approximately 20 households each. The path to one 
of these (Shamsabad) was blocked off in winter as it crosses an altitude of over 
10,000 feet.  Another group of households in Punial valley consistently refused 
government CHWs entry into their village prior to our project.  
High baseline respiratory rates among infants and young children residing at 
high elevations could possibly contribute to high pneumonia incidence rates. Disease 
that might not be classified as pneumonia at lower altitudes could result in respiratory 
rates sufficient to be classified as pneumonia at higher altitudes. This may also 
explain the small but significant population of children who have had recurrent 
pneumonia. It is also likely that many children in developing countries who have 
recurrent pneumonia have underlying asthma that predisposes to fast breathing even 
with mild illness.53 However, the IMCI classification of severe pneumonia is not 
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dependent upon the respiratory rate at the time of illness. Yet 8 out of 100 children 2 
to 35 years of age followed over the course of a year will develop severe pneumonia 
in this population. If we postulate that up to a third of the pneumonia cases reported 
were attributable to higher respiratory rates in children with mild respiratory 
infections, the incidence of  pneumonia would still be high (20 cases per 100 CYO).  
The lack of bacteriology services and small number of blood culture results 
available during the course of surveillance in Punial and Ishkoman limits our ability 
to determine the proportion of pneumonia that is attributable to specific pathogens. 
Viral infections, especially respiratory syncytial virus and influenza, are likely to be 
responsible for a large proportion of pneumonia in young children living in these 
communities. Efforts were underway to enhance diagnostic bacteriology capabilities 
in health centers, but conflicts in neighboring Afghanistan and terrorist attacks in 
Pakistan during 2002 resulted in decisions by donors to withdraw support for the 
second phase of this project. Further studies are needed to determine the etiology of 
the high burden of disease from pneumonia in these communities and consideration 
should be given to ‘probe’ trials using pneumococcal and Haemophilus influenzae 
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Table 1. Diagnostic classification for pneumonia, severe pneumonia and very severe febrile 
disease based upon the World Health Organization Integrated Management of Childhood Illness 
(IMCI) strategy for children aged 2-59 months.  
 




Cough or difficulty breathing (by history) and fast breathing b  
 
 
Severe Pneumonia a 
 
Cough or difficulty breathing (by history) and chest in-drawing 
or stridor or any general danger sign  c  
 
 
Very Severe  
Febrile Disease 
 




a  Pneumonia and Severe Pneumonia are mutually exclusive classifications under 
IMCI 
b  ≥50 breaths per minute in a child 2-11 months old or ≥40 breaths per minute in a 
child 12-59 months old 
c Defined as the presence of any one or more of the following signs: 1) inability to 




Table 2. Distribution and incidence of IMCI-classified pneumonia and severe pneumonia among children 2 to 35 months of age  
by altitude and health facility, Sep 2001 – December 2002, Punial and Ishkoman, Northern Areas of Pakistan. 
 
     














































































≥ 8,500 220 
(4) 














a Percent of all children enrolled at home  b Child years of observation (incidence rate based on cases reported at 15 health facilities 
 between November 1, 2001 and December 31, 2002)  c Facilities under surveillance; includes 2 government civil hospitals  
functioning at the level of primary health care centers during 2001 and 2002  d Percent of all pneumonia cases seen at all facilities  
under surveillance  e Not applicable
 
 29
Table 3. Characteristics of children aged 2-35 months with pneumonia and severe pneumonia 











Parental History                                            n(% or SD)         n(% or SD)   
Mother is information provider 1,256 (90%) 337 (88%) 
Mean age of children in months  12.1 (7.8) 11.7 (7.5) 
Male sex of the child 757 (52%) 201 (53%) 
Antibiotic received prior to current visit 110 (8%) 80 (20%) 
Co-trimoxazole 55 (4%) 34 (9%) 
Amoxicillin 46 (3%) 34 (9%) 
Others 4 (<1%) 4 (<1%) 
Child is able to breast feed or drink 1,396 331 (88%) 
Child vomits everything 0  79 (21%) 
Mean number of days - 2.1 (1.8) 
Child had convulsions 0 33 (9%) 
Mean number of days - 2.9 (1.7) 
Child has a cough 1,380 (99%) 366 (97%) 
Mean number of days 2.9 (2.5) 3.3 (2.8) 
Child has difficulty breathing 466 (33%) 263 (70%) 
Mean number of days 2.4 (3.0) 2.3 (1.7) 
Child has a fever 1,358 (97%) 350 (93%) 
Mean number of days 2.6 (1.4) 3.4 (6.1) 
If fever >7 days, present every day 9 (<1%) 11 (3%) 
Child has diarrhea 66 (5%) 35 (9%) 
Mean number of days 3.9 (7.2) 5 (3.8) 
Observation                                                        n(%)                  n(%)     
Lethargic/Unconscious 0 30 (8%) 
Febrile > 37.5 C 572 (41%) 193 (52%) 
Fast breathing 1,397  368 (98%) 
Chest indrawing 0 262 (70%) 
Stridor 0 144 (38%) 
Stiff neck 0 1 (<1%) 
Classification                                                     n(%)                  n(%)     
Correctly classified by health worker 1,376 (99%) 273 (72%) 
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Figure 2. Seasonal distribution of pneumonia and severe pneumonia (based upon World Health 
Organization Integrated Management of Childhood Illness classification) presenting to 19 health 











Figure 3. Incidence of pneumonia, severe pneumonia and the two combined (based upon World 
Health Organization Integrated Management of Childhood Illness classification) among 
children 2 to 35 months of age, Punial-Ishkoman, Northern Areas of Pakistan. November 1, 2001 








Incidence per 100 Child Years of Observation 
Age in Months 
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Table 4. Incidence of IMIC-classified pneumonia among children 2-35 months of age identified 
in Punial and Ishkoman, Northern Areas of Pakistan. November 2001-December 2002. 
 
Age Group 
Incidence Rate  
per 100 Child Years of Observations 
Age 2 - <3 months 71.2 
Age 3 - <4 months 66.5 
Age 4 - <5 months 92.1 
Age 5 - <6 months 71.8 
Age 6 - <7 months 69.2 
Age 7 - <8 months 45.3 
Age 8 - <9 months 46.2 
Age 9 - <10 months 49.5 
Age 10 - <11 months 35.2 
Age 11 - <12 months 40.0 
Age 12 - <13 months 44.4 
Age 13 - <14 months 35.7 
Age 14 - <15 months 41.7 
Age 15 - <16 months 36.1 
Age 16 - <17 months 38.5 
Age 17 - <18 months 30.9 
Age 18 - <19 months 28.8 
Age 19 - <20 months 35.6 
Age 20 - <21 months 27.6 
Age 21 - <22 months 29.1 
Age 22 - <23 months 32.2 
Age 23 - <24 months 22.2 
Age 24 - <25 months 23.0 
Age 25 - <26 months 19.7 
Age 26 - <27 months 23.3 
Age 27 - <28 months 16.4 
Age 28 - <29 months 19.4 
Age 29 - <30 months 9.8 
Age 30 - <31 months 12.0 
Age 31 - <32 months 7.9 
Age 32 - <33 months 5.9 
Age 33 - <34 months 7.0 
Age 34 - <35 months 16.2 




Table 5. Pneumonia incidence rate ratios for age, altitude, number of infants in a household, and 
gender as covariates in a Poisson regression. Punial and Ishkoman, Northern Areas, Pakistan. 
November 2001 – December 2002. 
  95% Confidence Limits 









Age Group  
(reference = 24-35 months) 
-   
Age 2 - <3 months 5.20 3.96 6.84 
Age 3 - <4 months 4.76 3.63 6.24 
Age 4 - <5 months 6.63 5.17 8.49 
Age 5 - <6 months 5.18 3.98 6.73 
Age 6 - <7 months 4.85 3.70 6.35 
Age 7 - <8 months 3.24 2.10 3.79 
Age 8 - <9 months 3.27 2.12 3.77 
Age 9 - <10 months 3.47 2.24 4.06 
Age 10 - <11 months 2.51 1.60 2.98 
Age 11 - <12 months 2.85 1.85 3.37 
Age 12 - <13 months 3.16 2.04 3.68 
Age 13 - <14 months 2.59 1.68 3.11 
Age 14 - <15 months 3.03 1.89 3.44 
Age 15 - <16 months 2.62 1.65 3.10 
Age 16 - <17 months 2.76 1.82 3.51 
Age 17 - <18 months 2.19 1.48 2.92 
Age 18 - <19 months 2.02 1.33 2.71 
Age 19 - <20 months 2.45 1.67 3.25 
Age 20 - <21 months 1.97 1.36 2.70 
Age 21 - <22 months 2.11 1.47 2.87 
Age 22 - <23 months 2.32 1.52 3.07 
Age 23 - <24 months 1.62 1.08 2.32 
Altitude range  
(reference = 5,500-6,499 feet) 
-   
Altitude range 6,500-7,499 feet 1.66 1.45 1.89 
Altitude range 7,500-8,499 feet 1.01 .92 1.30 
Altitude above 8,500 feet .15 .07 .32 
Children <36 months in household  
(reference = 0) 
-   
1-2 children <36 months in household 1.03 .91 1.17 
3 or more children <36 months in 
household 
.90 .40 2.00 
Gender 
(reference = Female) 
-   
Male 1.14 1.01 1.29 
a In comparison to reference group; bold font have p-value <0.05 
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Table 6. A comparison of community acquired pneumonia incidence rates at selected sites. 
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Background: Pakistan’s National Health Worker Program enlists community health 
workers (CHWs) to provide primary care services at home. This study was conducted 
to measure the impact of intensive follow-up training of CHWs on pneumonia 
recognition and referral. 
 
Methods: Ninety-nine CHWs were offered intensive follow-up training in the use of 
the World Health Organization Integrated Management of Childhood Illness (IMCI) 
guidelines every 6 weeks during the course of a 14-month cohort study. CHWs were 
evaluated by three methods: (1) their results on pre- and post-tests in multiple 
trainings targeted to address areas of weakness; (2) their assessment and referral of 
sick children with severe disease in the cohort during two-weekly home visits; (3) the 
calculated pneumonia incidence rates for children in their coverage area based upon 
paramedical staff and physician evaluations of children seen at health facilities. 
 
Results: Ninety-seven CHWs attended one or more training sessions (median 5, 
range 1-7). Significant improvements were reported between the pre- and post-test 
results of CHW in all 10 tests conducted (paired sample t-test p-value <0.001) over 
14 months. Mean post-test scores improved from 76.9% for those who attended 1-3 
trainings, to 79.2% for 4-5 sessions, and 89.3% for 6-8 sessions. The correct 
classification of IMCI general danger signs and appropriate referrals for severe 
pneumonia among children evaluated during home visits increased from zero to over 
80% over 14 months. The pneumonia incidence rates reported in children 2-35 
months of age in a CHW’s coverage area was 24 per 100 child years of observation 
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(CYO) for children served by CHWs who had attended 1-3 sessions, 29 per 100 CYO 
for CHWs who had attended 4-6 sessions, and 38 per 100 CYO for CHWs who had 
attended 7-8 sessions.  
 
Conclusion: Sequential follow-up training of CHWs in the use of IMCI guidelines 
resulted in sustained improvements in test performance and disease referral over the 
course of 14 months. Incorporating these training and evaluation methods should be 
considered for training of community health workers in all areas. Surveillance using 
less intensively trained CHWs is likely to lead to an underestimation of the true 





 The World Health Organization (WHO) Integrated Management of 
Childhood Illness (IMCI) strategy has been endorsed by the Government of Pakistan 
as an effective tool to reduce early childhood morbidity and mortality from 
pneumonia, diarrhea, malnutrition, measles and malaria.54 The strategy focuses upon 
1) health systems development, 2) case management at first-level health care facility, 
and 3) community and family knowledge and practices. The strategy and plan for the 
implementation of the third element of IMCI have not been finalized in Pakistan. The 
government-run National Health Worker Program enlists village-based, community 
health workers (CHWs) to make monthly household visits and provide primary care 
services at home. CHWs are trained to screen children for signs and symptoms that 
require referral and to treat simple illnesses according to WHO guidelines. Sick 
children are preferentially referred to government health centers.  
The purpose of this study was to determine whether intensive follow-up 
training of government CHWs in the use of IMCI guidelines (Table 7) would result 
in improved (1) average pre- and post-test scores, (2) detection and appropriate 
referral of children who have general danger signs or severe pneumonia, and (3) 




The Punial and Ishkoman valleys of the Northern Areas had an estimated 
population of 59,000 in 2001.55 Villages in Punial are situated at altitudes of 5,500-
6,499 feet and in Ishkoman between 6,500-9,499 feet. The temperature ranges from 
 
 40
40° C in July to -20° C in January. A household commonly includes more than one 
generation of married couples sharing a dwelling and kitchen. Farming is the primary 
means of livelihood.  
Village-based organizations and volunteers working with the Aga Khan 
Development Network (AKDN) have brought about significant improvements in 
agricultural practices, literacy and health.56 Areas served by the Aga Khan Health 
Service Pakistan (AKHSP) primary health care (PHC) program have had reductions 
in infant mortality rates (IMR) from above 100 per 1,000 live births in the 1988 to 
below 40 per 1,000 live births in 2000. In comparison, IMR decreased less 
substantially in other areas in Pakistan (from above 100 per 1,000 to 94 per 1,000 in 
2000). Eighty four percent of children served by AKHSP had received all EPI-
recommended vaccines by 1 year of age in 2001 in comparison to less than 40% of 
children by 1 year of age in adjacent, non-AKHSP program areas. Over 60% of 
infants in AKHSP areas were exclusively breast-fed till 4 months of age compared to 
less than 30% of children in adjacent areas.57  However, 22% of infants and 24% of 
children in the study area 1-4 years of age have grade 1 malnutrition. The Aga Khan 
Health Service and Government of Pakistan health system in Punial and Ishkoman 
are described in detail in Paper 1.58 
 
Training and Materials 
The IMCI training program for first-level health facility-based paramedical 
staff and physicians involves an 11-day program. However, a standardized IMCI 
training program has not been developed for CHWs by WHO.59 IMCI training 
materials for first-level health facility staff were adapted for CHWs and translated 
into Urdu by a preventive medicine resident from Johns Hopkins certified as an IMCI 
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Master Trainer. 60 The four-page booklet developed in collaboration with the Aga 
Khan Health Service Pakistan (AKHSP) Health Promotion Resource Centre included 
the modules for “general danger signs” and “cough and difficulty breathing” on page 
1, “fever” on page 2, and the “child less than 2 months” on page 3, exactly as 
outlined in the IMCI training materials for personnel at first-level health facilities. 
The fourth page included patient management and counseling guidelines, but these 
were modified to keep them appropriate to the educational level of the CHWs and in 
accordance with the guidelines of the National Health Worker Program. All of the 
recommendations made by the national IMCI expert committee during 2000 were 
incorporated into these training materials. Additional wall charts and manuals in 
English and Urdu were later procured from the National IMCI Coordinator as they 
became available and used in the training. IMCI training was simultaneously 
conducted for paramedical staff and their supervising physician (where present) at 15 
first-level health facilities in Punial and Ishkoman. Children referred by CHWs to 
these facilities were generally managed in accordance with IMCI guidelines, 
although physicians and paramedical staff were not compelled to do so. 
 
Baseline Training and Enrollment 
Beginning in July 2001 onwards, all 99 government CHWs across Punial and 
Ishkoman were given three-day introductory training at their assigned health center 
using the IMCI materials developed for them. This was followed by two-weeks of 
closely supervised home visits to enroll children after consent using surveillance 
forms. Initial enrollment of children less than 24 months old was completed at all 
sites by November 2001; ongoing enrollment of newborns continued until December 
31, 2002. For details on surveillance methods, see Paper 1.4 
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Follow-up IMCI Training for CHWs 
Follow-up training was conducted by an AKHSP community health nurse 
with extensive experience of training health workers in the Northern Areas, who was 
also certified as an IMCI Master Trainer. While training was conducted primarily in 
Urdu, she used two of the local languages (Sheena and Khwar) to translate words or 
concepts as necessary. Each training session began with a revision of the IMCI 
booklet developed for CHWs. IMCI modules on diarrhea, sore throat, ear problem 
and malnutrition and anemia were subsequently added over the course of the year. 
The program combined classroom work using a mother's card, a photo exercise 
booklet, wall charts and videos followed by evaluations of sick patients visiting 
health facilities. Knowledge and evaluation skills covered during training included: 
assess and classify the sick child age 2 months up to 5 years; determine the need for 
referral; treat the child if required; counsel the mother; and follow-up at home. 
Training sessions generally lasted from between 4-6 hours, and CHWs were asked to 
attend follow-up training every 6 weeks during which they would also be evaluated 
using pre- and post-tests. 
 
Pre- and Post-tests 
At the beginning of each training session, attendees were administered a pre-
test to complete independently within 15 minutes and the same test was administered 
at the end of the training day. Tests were adapted from exercises in the IMCI training 
materials produced by the Ministry of Health in collaboration with the WHO and 
UNICEF for facility-based paramedical staff.61 All tests were conducted in Urdu. 
Each test evaluated a CHWs comprehension of the general danger signs; the signs, 
symptoms and classification of pneumonia and severe pneumonia; and appropriate 
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referral decisions for seriously ill children. Other IMCI classifications that were also 
routinely covered included Very Severe Febrile Disease, Serious Bacterial Infections 
and the three categories of measles and its complications. Tests were graded by the 
AKHSP IMCI Master Trainer. There were between 10-15 questions per test and a 
maximum of 20 points could be obtained. For smaller groups and those located in 
difficult to access areas, pre- and post-tests were graded at the end of the training day 
and reviewed with individual CHWs. For larger groups, CHWs were visited at their 
homes or their assigned centers within a week of the training. Discussions focused on 
areas identified as weaknesses in the post-tests. If the same area of weakness was 
identified for 2 or more members of a training group, it was reviewed again with the 
whole class during the next follow-up training. The questions varied for pre- and 
post-test exams by providing different scenarios and decision outcomes to allow the 
IMCI Master Trainer to target areas of weakness. Pre- and post-test evaluations for 
follow-up training began in November 2001 after CHWs in all regions of Punial and 
Ishkoman had completed baseline training and enrollment. Follow-up training and 
evaluations were conducted every six weeks until December 2002, 
 
Enrollment and Recognition of General Danger Signs and Referral of Sick Children 
CHWs enrolled all children in their coverage area under 24 months of age at 
the beginning of the surveillance project and continued enrollment of newborns until 
December 2002. Children were followed at home every two weeks and screened 
using the Home Visit Form. (See Appendix) Sick children were assessed using the 
Disease Information Form, which required the CHW to identify general danger signs 
and determine the need for referral. Information was collected using Home Visit 
Forms and Disease Information Forms between July 25 2001 and August 31 2002, at 
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which time two-weekly household visits were discontinued because of lack of 
funding. Home based enrollment of all newborns continued until December 2002. 
 
Pneumonia Incidence Data 
Health center staff used IMCI criteria to screen children 2-35 months of age 
presenting to first-level health facilities for pneumonia or severe pneumonia. Health 
center staff identified all children with cough or difficulty breathing and one or more 
of fast breathing, chest indrawing, stridor, or any general danger signs were 
evaluated. Facility based surveillance for pneumonia was fully established in Punial 
and Ishkoman by November 3, 2001 and continued until December 2002. 
 
Monitoring 
CHWs were visited by the AKHSP IMCI Master Trainer and a data editor 
every three weeks to review home visit schedules, data forms, IMCI classification of 
disease and referral practices. A quality management form was used to evaluate each 
CHWs adherence to home visit schedules. CHWs were also assessed for their 
comprehension of IMCI guidelines for the recognition of general danger signs and 
referral of disease.  
 
Data Management 
Surveillance forms were optimized for scanning and optical character 
recognition. TELEform® 6 was used for data capture, Microsoft Access® 2000 for 
checking data integrity, and SPSS® version 11.5 for data analysis. Information 
collected at the time of home-based enrollment and on subsequent home visits was 
linked with the information collected at participating health facilities. If the child’s 
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surveillance number was unavailable, additional information collected at the time of 
the facility visit permitted us to procure the surveillance identification number at a 
later date. Pre- and post-test forms were graded by hand and the final score entered 
into a Microsoft © Excel sheet.. 
 
Statistical Methods 
The mean difference between pre- and post-test scores at each training was 
compared using a paired sample t-test. The difference in the means of scores for two 
groups was compared using a student’s t-test. The presence of differences between 
groups when comparing three or more groups was measured using one-way analysis 
of variance (ANOVA). To measure the differences in pneumonia incidence rates 
among children based on a CHW’s performance on post-tests, CHWs were 
categorized into three groups by their mean post-test scores (90% or higher, 80%-
89.9% and <80% on their post-tests). The numbers of trainings attended were 
categorized into three groups (1-3, 4-5 and 6-8). Incidence rates for pneumonia and 
severe pneumonia were calculated for children in a CHWs coverage area by counting 
the cases from the area that presented to health facilities as the numerator and 
summing the total years of observation for all children in the area as the denominator. 
Altitude was categorized into four groups (5,500-6,499, 6,500-7,499, 7,500-8499, 
and 8,500 and above) for ease of comparison. CHW ages were categorized into three 
age groups (15-24, 25-29, 30 and above). Experience in the NHW Program was 







This study was approved by the institutional review boards (IRB) at the Johns 
Hopkins Bloomberg School of Public Health and the Aga Khan University. Written 
informed consent was obtained from the parents or legal guardians of children 
enrolled at home or at the time of health facility visits. 
 
Results 
CHW Characteristics and Training 
The mean age of CHWs was 28 years (range 17-36) and 73 (75%) worked for 
the National Health Worker Program for 5 or more years. Nine CHWs were single, 
86 were married and 2 were widowed. Seventeen CHWs (18%) had no children, 24 
(25%) had 1-2, and 56 (57%) had 3 or more children. Forty-nine (51%) lived at 
between 5,500-6,499 feet, 32 (33%) between 6,500-7,499 feet, 13 (13%) between 
7,500-8,499 feet and 3 (3%) at 8,500 feet or above. 
  Training sessions were conducted at government or AKHSP health centers 
based upon their accessibility to CHWs. Ninety-seven CHWs attended a median of 5 
training sessions (mean 4.7, mode 5, range 1-7) out of the 10 offered during 14 
months. Two CHWs out of 99 did not attend any IMCI follow-up sessions following 
their baseline training. One had completed enrollment of eligible children in her 
village but was subsequently refused permission by male members of her family to 
attend training sessions. The second CHW was recruited into the government 
program in early 2002 but then went on an extended maternity leave.  
No significant differences (one-way ANOVA p-value > 0.1) were noted in the 
mean number of training sessions attended based on the CHW’s age marital status, 
number of children, number of people living in her household, and the household 
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income per number in household. CHWs living at altitudes above 8,500 feet attended 
significantly fewer training sessions (mean of 2.3, p-value =0.025) than CHWs living 
at 5,500-6,499 feet (4.7), 6,500-7,499 feet (4.8) or 7,500-8,499 feet (4.15). CHWs 
who had been working in the government program for less than 2 years also attended 
fewer follow-up training sessions (mean of 3.3, p-value< 0.001) than those who were 
recruited between 1994-1995 (4.8) and 1996-1998 (5.0) . A total of ninety-one 
training sessions were held over the course of 14 months. The median size of a 
training group was 7 (range 2-36).  
 
Pre- and Post-test Scores. 
Pre-tests scores averaged 72.7% at the first follow-up training, 52.5% at the 
third training, and 79.0% at the ninth training.  The mean post-test scores were 80.9% 
at the first follow-up training, 70.8% at the third, and 90.9% at the ninth. The pre- 
and post-test scores for all 10 tests conducted are shown in Figure 4. Significant 
improvements were reported between the pre- and post-test results of CHW in all 10 
tests conducted (paired sample t-test p-value <0.001) over 14 months. Mean post-test 
scores also improved by the total number of training sessions attended, from 62.7% 
to 76.9% for those who attended 1-3 sessions, 67.2% to 79.2% for 4-5 sessions, and 
78.0% to 89.3% for 6-8 sessions. Mean pre- and post-test scores were significantly 
lower for those aged 15-24 years (64.2% to 77.5%) in comparison to those aged 25-
34 years (69.4% to 81.2%, p-value < 0.05) and 35-44 years (71.4% to 83.5%, 
p<0.05). The distribution of CHWs and the reported incidence rates for pneumonia 
and severe pneumonia among enrolled children are shown in Table 8. CHWs living 
at higher altitudes attained lower pre- and post-test averages than CHWs living at 
lower altitudes (p-value<0.02) (Table 9). CHWs that had been working in the 
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government program for less than 2 years prior to the start of surveillance also 
attained lower mean pre-test (61.1%) and post-test (73.2%) scores than CHWs 
recruited between 1994-1995 (70.8% and 83.9%) and 1996-1999 (70.9% and 82.7%) 
into the government program (p-value< 0.02). 
 
Identification and Referral of General Danger Signs and Severe Pneumonia during 
Home Visits 
           The correct classification of IMCI general danger signs and severe pneumonia 
and their appropriate referral increased from below 40% in October of 2001 to over 
80% in August 2002. (Figure 5)  
 
Pneumonia Incidence Rates by CHW Coverage Area 
         The incidence of pneumonia among children living in areas served by CHWs 
that achieved high mean post-test scores (90% or above) was higher than for children 
served by CHWs who achieved lower scores (Figure 6). Details of pneumonia 
incidence rates by altitude are shown in Table 8.   
 
Discussion 
          Many of the guidelines from the original WHO Acute Respiratory Infections 
(ARI) Control and Control of Diarrheal Disease Programs were incorporated into the 
IMCI strategy. The inclusion of these earlier guidelines in the training of government 
CHWs at the time of entry into the program and during the course of their work 
provided them the knowledge and skills that helped them to assimilate and 
implement IMCI guidelines. 
 
 49
CHWs dropped their mean pre- and post-test scores for training D. This was a 
result of the change from repeated testing focusing on comprehension of general 
danger signs, pneumonia and severe pneumonia to more complex case scenarios and 
inclusion of additional IMCI modules such as for diarrheal disease. From training D 
onwards, CHWs improved and maintained their performance during the course of the 
follow-up training. However, the duration of these benefits beyond the last training 
was not measured.  
The National Health Worker Program in the Northern Areas of Pakistan can 
improve CHW performance by providing follow-up training and evaluation at regular 
intervals. The cost and feasibility of implementing similarly intensive follow-up 
trainings and supervision of CHWs over a one-year period should be evaluated by the 
NHW Program managers. Some of the challenges in implementing such a program 
will include determining strategies to reach the CHWs need the most support. These 
may include targeting those with shorter duration of work experience or those living 
in less accessible areas. This intensive training program can also provide other 
important benefits, including a more accurate assessment of disease burden in the 
community. In settings where up to 40% of childhood deaths may be attributable to a 
single IMCI classified illness, the improved accuracy in measuring disease burden 
can result in better allocation of program resources and the potential for more 
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Table 7. Diagnostic classification for pneumonia and severe pneumonia based upon the World 
Health Organization Integrated Management of Childhood Illness (IMCI) strategy for children 
aged 2-59 months.  
  
 




Cough or difficulty breathing (by history) and fast breathing b  
 
 
Severe Pneumonia a 
 
Cough or difficulty breathing (by history) and chest in-
drawing or stridor or any general danger sign c  
 
 
a  Pneumonia and Severe Pneumonia are mutually exclusive classifications under 
IMCI 
b  ≥50 breaths per minute in a child 2-11 months old or ≥40 breaths per minute in a 
child 12-59 months old 
c Defined as the presence of any one or more of the following signs: 1) inability to 
breastfeed or swallow fluids; 2) persistent vomiting; 3) convulsions; and 4) 







Figure 4. Mean pre- and post-test scores achieved by government community health workers trained in the use of World Health Organization Integrated 
















    A      B      C       D      E       F      G       H       I       J 
TEST 




Table 8. Distribution of Government CHWs1, enrolled children and pneumonia incidence by altitude (in feet), Punial Ishkoman, Northern Areas of Pakistan, 
November 2001-December 2002. 
Punial and Ishkoman All Altitudes 5,500-6,499 feet 6,500-7,499 feet 7,500-8,499 feet ≥8,500 feet 
Government CHWs 99 51 32 13 3 
Children 2-35 months of age 











Pneumonia Incidence2 29.9 20 40.2 30.5 NA 
Severe Pneumonia Incidence2 8.1 8.7 8.5 11 18.4 
1 Community Health Workers employed by the government National Health Worker Program. 2 Incidence per 100 child years of observation
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Table 9. Distribution of mean pre- and post-test scores achieved in follow-up trainings for Government CHWs by altitude (in feet), Punial Ishkoman, Northern 
Areas of Pakistan, November 2001-December 2002. 
Punial and Ishkoman All Altitudes 5,500-6,499 feet 6,500-7,499 feet 7,500-8,499 feet ≥8,500 feet 
 
Follow-up Training  
 
Mean Pre-test Score / Mean Post-test Score [Number of CHWs that Attended Training] 
 
A 72.7 / 80.9   [60] 76.9 / 83.9   [36] 65.7 / 76.9   [22] 72.7 / 75.0     [2] [0] 
B 82.1 / 88.4   [58] 84.5 / 90.9   [39] 78.9 / 86.4   [11] 75.0 / 80.3     [8] [0] 
C 77.2 / 87.2   [37] 82.3 / 90.0   [10] 85.8 / 92.6   [16] 67.1 / 87.5     [8] 40.9 / 48.5     [3] 
D 52.5 / 70.8   [54] 48.1 / 71.8   [32] 60.2 / 70.9   [18] 53.3 / 62.5     [4] [0] 
E 58.0 / 72.8   [32] 58.3 / 65.8     [4] 63.2 / 75.5   [17] 50.0 / 71.0   [10] 43.3 / 73.3     [1] 
F 63.0 / 78.4   [49] 61.8 / 79.4   [36] 73.3 / 82.2     [9] 43.3 / 53.3     [1] 50.0 / 65.4     [3] 
G 68.5 / 81.5   [50] 68.3 / 84.9   [24] 70.0 / 75.4   [18] 65.4 / 84.6     [8] [0] 
H 77.6 / 89.2   [59] 75.7 / 91.0   [28] 80.0 / 87.1   [25] 76.1 / 88.9     [6] [0] 
I 79.0 / 90.9   [43] 81.0 / 91.2   [28] 79.1 / 89.4   [11] 65.0 / 89.2     [4] [0] 
J 84.5 / 88.8   [11] 64.4 / 71.1     [3] 92.8 / 95.0     [6] 90.0 / 96.7     [2] [0] 
1 Community Health Workers employed by the government National Health Worker Program.
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Figure 5. Proportion of children 2-35 months of age with general danger signs and severe pneumonia (based upon World Health Organization Integrated 
Management of Childhood Illness criteria) correctly classified by government community health workers and appropriately referred to a first-level health facility 









Figure 6. Differences in the incidence of pneumonia (World Health Organization Integrated Management of Childhood Illness classification of pneumonia and 
severe pneumonia) in children 2-35 months living by the mean score achieved on all post-tests taken by government community health workers in Punial and 
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Paper 3: Comparison of health center staff classification of pneumonia based on 
WHO IMCI criteria with evaluation by pediatricians in an outpatient setting in 
Gilgit, Pakistan 
 
Aamir Khan1,2, Saad Omer1, Hamidah Hussain1, Azizullah Baig2, Zafar Fatmi3, 
Fauzia Ajmal3, Sajida Chaudry4, Imam Yar Baig5, Rozina Mistry5, Neal Halsey1 
 
1 Department of International Health, Johns Hopkins Bloomberg School of Public 
Health 
2 Center for Health Interventions Research, Gilgit 
3 Community Health Sciences Department, Aga Khan University 
4 Preventive Medicine Resident, Johns Hopkins Bloomberg School of Public Health 





Background: World Health Organization Integrated Management of Childhood 
Illness (IMCI) criteria were used to evaluate ill children living in a Himalayan region 
of Pakistan. This study assessed health center staff classification of pneumonia using 
a pediatrician’s evaluation as gold standard.  
 
Methods: Two health center staff used IMCI criteria to screen children between 2-35 
months of age presenting to a pediatric out-patient department at a government 
tertiary care facility for pneumonia or severe pneumonia. Children with cough or 
difficulty breathing and one or more of fast breathing, chest indrawing, stridor, or 
general danger signs were evaluated by pediatricians whose clinical diagnosis served 
as the standard reference for comparison.  
 
Results: Health center staff screened 32,213 children presenting to the clinics over a 
14-month period. Of the 3,438 children with one or more IMCI criteria, 2,864 
(83.3%) were classified as having pneumonia and 453 (13.2%) as having severe 
pneumonia by the health center staff. Pediatricians diagnosed 3,145 (91.5%) children 
with pneumonia and 167 (4.9%) with severe pneumonia. The overall agreement 
between staff and pediatricians was 87.2% for pneumonia (kappa of .427, p<0.001) 
and 89.2% for severe pneumonia (kappa of .358, p<0.001). Using the pediatrician’s 
diagnosis as gold standard, staff correctly classified 2,784 (88.5%) of the children 
with pneumonia and failed to identify 361 (11.5%) of the children with pneumonia.  
Staff correctly classified 125 (74.9%) of the children with severe pneumonia, and 
failed to identify 42 (25.1%) of the children with the disease. Of the 453 children 
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classified as severe pneumonia by staff, 328 (72.4%) were incorrectly assigned the 
classification.  
 
Conclusion: Health center staff trained in the use of IMCI criteria correctly classified 
the majority of children with signs or symptoms of pneumonia. However, 
misclassification of severe disease by staff using IMCI criteria can result in an 
overestimation of severe disease incidence rates. Consideration should be given to 
conducting similar evaluations in other populations to determine if adjustments 





 The World Health Organization (WHO) Integrated Management of 
Childhood Illness (IMCI) strategy has been endorsed by the Government of Pakistan 
as an effective tool to reduce early childhood morbidity and mortality from 
pneumonia, diarrhea, malnutrition, measles and malaria.62 The strategy is focused 
upon 1) health systems development, 2) case management at first-level health care 
facility, and 3) community and family knowledge and practices. The plans for the 
implementation of the second element of the IMCI strategy have been finalized by 
the Ministry of Health but have yet to be implemented. 
Training facility-based health workers in the use of IMCI guidelines results in 
significant improvements in the care provided, including improvements in the correct 
classification of disease.63 In the north-western states of Brazil, IMCI trained health 
workers were twice as likely to check for signs of cough, diarrhea or fever and 
correctly classify a sick child in comparison to those not trained in IMCI.64 Similar 
observations have been made in other countries in the multi-country evaluation 
(MCE) of the IMCI strategy during the 1990s. In a 1997 evaluation of facility-based 
government health workers trained in IMCI guidelines in the Western Province of 
Kenya, the proportion of children who were correctly classified with pneumonia fell 
from 90% at the end of training to 78% in the 1-3 months post-training period.65 The 
study also found that misclassification was more common for more severe diseases, 
with just 45% of children with severe pneumonia correctly classified at the end of 
training declining to 32% at 1-3 months post-training. 
The classification of pneumonia and other clinical syndromes in IMCI is 
based upon detection of a few key signs and symptoms.66  At the Medical Research 
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Council (MRC) Laboratories in the Gambia, health worker’s classification of 
pneumonia as measured against a pediatrician diagnosis had a sensitivity of 81% and 
a specificity of 89%, but pneumonia and severe pneumonia were not reported 
separately in this study.67 A severe pneumonia classification by health workers who 
had received one-week training in IMCI guidelines at a rural district hospital in 
western Uganda had low sensitivity (53%) and high specificity (93%). In a similar 
evaluation in Tanzania, diseases that were more severe were less likely to be 
classified correctly (60% for severe pneumonia versus 92% for pneumonia). 68 The 
Tanzania study conducted the full 11-day IMCI training course for facility-based 
health workers, at the end of which there were demonstrable improvements in the 
assessment, classification and treatment of sick children. The sensitivity and 
specificity of the IMCI criteria have not been reported in a Pakistani setting. 
The purpose of this study was to determine the proportion of children with 
pneumonia or severe pneumonia as diagnosed by a pediatrician that were 
misclassified by health center staff using IMCI criteria. The study was conducted at 
the major referral hospital in Gilgit in the Himalayan regions of Pakistan, where 
pediatricians were available to provide a clinical diagnosis that could serve as a 
standard for comparison with the diagnosis of health center staff. This study 
complemented a larger cohort study conducted simultaneously in Punial and 
Ishkoman valleys, a 2- to 6-hour jeep-ride north-west of Gilgit depending upon the 
final destination. In that study (see Paper 1), health center staff based at first-level 
health facilities were trained in the use of IMCI guidelines and conducted pneumonia 
surveillance between November 2001 and December 2002. Children were enrolled at 
home by community health workers (see Paper 2) and screened for cough or 
difficulty breathing and one or more of fast breathing, chest indrawing, stridor, or 
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general danger signs by health center staff when they presented to participating 
health center. At the end of surveillance in Punial and Ishkoman, incidence rates for 
pneumonia were calculated based on the reported number of cases at health centers 
and months of follow-up. This validation study in Gilgit used pediatricians’ clinical 
diagnosis as a standard against the diagnosis of health center staff to determine 
whether the reported incidence rates for pneumonia in Punial and Ishkoman required 




Gilgit is the administrative head quarters of the Northern Areas of Pakistan 
with an estimated population of 40,000 in 2001.69 The town is situated within an 
altitude range of 4,500-5,499 feet and is readily accessible throughout the year by 
road from Hunza and Nagar valleys in Gilgit district and Punial and Ishkoman 
valleys in Ghizer district. The temperature ranges from 40° C in July to -5° C in 
January. While small farms on the periphery of the town provide staple foods for 
many households, the primary means of livelihood comes from trade and 
employment in the military, government and private sector. 
The Gilgit District Head Quarter (DHQ) Hospital serves as the major referral 
hospital in the Northern Areas. Established in 1939, the DHQ Hospital is a 214 bed 
facility with a uniformed military officer as its administrative head. It is relatively 
well-equipped and funded in comparison to government district hospitals in other 
provinces. There were three full-time pediatricians serving an out-patient department 
(OPD) that averaged between 150-200 visits a day and a 20-bed in-patient pediatric 
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ward. On working days (Monday-Saturday), two pediatricians conducted out-patient 
clinics between 8 am to 2 pm while the third conducted in-patient rounds.  
Patients presenting to the OPD were assigned a number by hospital staff in 
the waiting room. All patients between 2-35 months of age in the waiting area were 
screened by health center staff using IMCI criteria for the presence of cough or 
difficulty breathing and one or more of fast breathing, chest indrawing, stridor, or 
general danger signs. Written consent was sought from parents or guardians to enroll 
children who met these criteria. A history and observation based on IMCI assessment 
guidelines were carried out by the health center staff who assigned an IMCI 
classification of disease on the study form. (Table 10) The child was referred (with 
the study form) to one of the pediatricians in the OPD. During our initial discussions 
at the Gilgit DHQ hospital, the pediatricians had stated their inability to conduct a 
detailed physical examination and fill a study form given the number of patients they 
saw during the OPD. Upon their suggestion, a study physician was recruited to sit 
alongside one of the pediatricians to conduct a physical examination on all children 
referred by health center staff and to fill the study form and present the findings to 
the pediatrician. The pediatrician reviewed the findings and made a diagnosis using 
the IMCI classification of disease for pneumonia or severe pneumonia, which was 
noted on the study form. All treatment decisions were made by the pediatrician, who 
wrote out separate prescriptions and advised hospital admission or follow-up visits. 
The pediatricians in the OPD saw all 32,213 children 2-35 months of age during this 
14 month period and referred a small number of patients back to the paramedical 
staff whom they considered eligible for the study that were missed based on the IMCI 




Training and Materials 
Training materials in Urdu had been translated by a preventive medicine 
resident from Johns Hopkins certified as an IMCI Master Trainer working in 
collaboration with the AKHSP Health Promotion Resource Centre. All of the 
recommendations made by the national IMCI expert committee during 2000 were 
incorporated into these training materials. Additional wall charts and manuals in 
English and Urdu were later procured from the national IMCI coordinator as they 
became available.  
Two health center staff were recruited based on their work experience at first-
level health facilities. In Pakistan, a common type of health center staff are women 
who are traditionally called Lady Health Visitors (LHVs). LHVs have 12 years of 
schooling and are trained for one year each in nursing and midwifery. AKHSP health 
centers are staffed by two LHVs trained to diagnose common medical conditions and 
prescribe medications (including antibiotics) using established WHO IMCI 
guidelines. Many government health centers also have an LHV posted to them. One 
of the health center staff on this study was an AKHSP LHV. A second common type 
of health center staff in Pakistan are men who are traditionally called dispensers. 
Dispensers may have 12 years of schooling but are not required to do so. They 
usually receive training with a general physician (GP) as an assistant and their role 
involves preparing patients for physical exams, dispensing common drugs prescribed 
by doctors and administering injections. Training occurs on the job and may include 
running the GP clinic as the principal health care provider while the GP is out. Many 
dispensers intern with government medical officers in the morning and at private 
clinics at evenings. The second health center staff on this study was a dispenser at a 
government health center. 
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The study physician assigned to support the pediatrician in evaluating patients 
was the best graduate of his medical school class and had completed an internship at 
a government hospital. He had also completed a 6 month rotation in a pediatric ward 
at the Chilas DHQ hospital (two hours from Gilgit) under the supervision of the 
senior pediatrician who was later reassigned to the Gilgit DHQ hospital and also 
participated in this study.  
 Health center staff were trained and evaluated prior to the beginning of 
surveillance and at regular intervals thereafter using the same training program 
developed for health center staff in Punial and Ishkoman. This training program was 
based upon but was not the standard 11-day IMCI training, because the government 
and AKHSP health center staff could not leave their assigned duties for that long a 
duration. The training we provided to health center staff in Punial and Ishkoman (and 
the two health center staff participating in this study) included a two-day classroom 
review of IMCI criteria in October 2001, with an emphasis on the modules for 
general dangers signs and cough or difficulty breathing. The Ministry of Health IMCI 
booklet for assessing, classifying and treating the sick child age 2 month up to 5 
years was a key component of this training, with an emphasis on the modules for 
general danger signs, cough or difficulty breathing and fever. Training also included 
extensive use of the IMCI photo exercise booklet, wall charts and videos. Training on 
sick patients visiting health facilities was supervised by the IMCI Master Trainer 
from AKHSP and study coordinators.  
In Punial and Ishkoman, training was followed by visits every three weeks 
conducted by a study physician to the health centers to review the use of IMCI 
guidelines with individual health staff. Each visit involved reviewing IMCI charts 
and evaluation of patients present at the time. The study physician visits continued 
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until December 2002. A seperate study physician and three pediatricians at the Gilgit 
DHQ hospital were trained once just prior to the beginning of surveillance, and then 
6 months later. The senior pediatrician was the coordinator for the National Acute 
Respiratory Infections (ARI) Control Program for the Northern Areas and the two 
other pediatricians had received multiple trainings under this program.  
A provision had been made to report findings on chest radiographs but a 
policy was implemented at the DHQ a few months prior to the start of this study 
prevented the administration from charging chest radiograph costs to patients, 
resulting in the inability of the radiology unit to generate funds for the purchase of 
films and chemicals. The limited supplies that could be procured within the DHQ 




The classification of pneumonia and severe pneumonia by health center staff 
and pediatricians were cross-tabulated to determine: the proportion of children they 
agreed upon (overall agreement and kappa statisitic); the number of children missed 
by the health center staff using the pediatricians diagnosis as reference; and the 
number of children incorrectly identified as having the disease by health center staff. 
Adjustments in disease incidence rates were made by adding the number of children 
missed and subtracting the number of children incorrectly identified as having the 
disease to the numerator. Forms used at the site were optimized for scanning and 
optical character recognition. TELEform® 6 was used for data capture, Microsoft 





This study was approved by the institutional review boards (IRB) at the Johns 
Hopkins Bloomberg School of Public Health and the Aga Khan University. Written 
informed consent was obtained from parents or legal guardians prior to enrollment. 
 
Results 
A total of 59,654 children presented to the Gilgit DHQ Hospital OPD 
between November 1, 2001 and December 31, 2002. Health center staff screened 
32,213 children between 2-35 months of age and identified 3,438 children with 
cough or difficulty breathing along with any one of fast breathing, chest indrawing, 
stridor, or any general danger sign. Information on these 3,438 children and the signs 
and symptoms reported by the physician at Gilgit DHQ Hospital are presented in 
Table 11.  
Health center staff screened 32,213 children presenting to the clinics over a 
14-month period. Of the 3,438 children with one or more IMCI criteria, 2,864 
(83.3%) were classified as having pneumonia and 453 (13.2%) as having severe 
pneumonia by the health center staff (Table 12). Pediatricians diagnosed 3,145 
(91.5%) children with pneumonia and 167 (4.9%) with severe pneumonia. The 
overall agreement between staff and pediatricians was 87.2% for pneumonia (kappa 
of .427, p<0.001) and 89.2% for severe pneumonia (kappa of .358, p<0.001).  
Using the pediatrician’s diagnosis as reference, health center staff correctly 
classified 2,784 (88.5%) of the children with pneumonia and failed to identify 361 
(11.5%) of the children with pneumonia.  Of the 2,864 children classified with 
pneumonia by health center staff, 80 (2.8%) were incorrectly assigned the 
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classification. Similar comparisons for key IMCI signs and symptoms for pneumonia 
and general danger signs are presented in Table 12.  
 Examined by age, the proportion of children with pneumonia missed by 
health center staff was 10.3% among children 2-11 months of age, 11.4% in those 12-
23 months and 15.7% in those 24-35 months (Table 13).  The proportion of children 
that were incorrectly labeled as having pneumonia by health center staff was 2.2-
3.1% in each of these age categories. The proportion of children with severe 
pneumonia that was missed was 21.4% among children 2-11 months of age, 37.9% 
for those 12-23 months and 28.6% for those 23-35 months (Table 14). The proportion 
of children that were incorrectly labeled as severe pneumonia when they did not have 
severe pneumonia was 62.9% for those 2-11 months, 85.9% for those 12-23 months 
and 80.5% for those 24-35 months.  
The mean age of children with pneumonia was similar (t-test p-value >0.05) 
between Gilgit DHQ Hospital (13.2 months) and the health centers in Punial and 
Ishkoman (12.1 months) (Table 11).  The mean age of children with severe 
pneumonia was also similar (t-test p-value >0.05) between the Gilgit DHQ Hospital 
(10.4 months) and the health centers in Punial and Ishkoman (11.7 months). A larger 
proportion of children at the Gilgit DHQ Hospital were male (63% versus 53% for 
the entire population) and fewer were accompanied by their mothers (58% versus 
90% respectively). Children with pneumonia in Gilgit had more signs and symptoms 
for longer average durations and had higher antibiotic usage (36% versus 8%) than 
children presenting to health centers in Punial and Ishkoman. 
Assuming the pediatrician assessment rates are the correct diagnoses and that 
the rates of over and under-diagnoses for health center staff were similar throughout 
the area, the incidence rates for pneumonia should be adjusted from the observed 
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29.9 per 100 CYO to 32.5 per 100 CYO (Table 13). The incidence rates for severe 
pneumonia should be adjusted from 8.1 per 100 CYO to 4.3 per 100 CYO (Table 14).  
 
Discussion  
Training facility-based health workers in the use of IMCI guidelines results in 
significant improvements in the care provided, including improvements in the correct 
classification of disease. The over-classification of severe disease found in this study 
is expected when using IMCI criteria, as these were designed to minimize the risk of 
not referring children who might have severe disease to a higher level health facility. 
Health center staff in this study did not receive the standard 11-day IMCI training, 
but did receive much more critical review and training on site every three weeks over 
one year. Given the limitations placed by program managers from the government 
and AKHSP, the 11-day standard IMCI course was not feasible.  
 Fast breathing was common in the 3,438 children identified through 
screening, and was very rarely missed or mistakenly assigned to children who did not 
have it. Because fast breathing can be objectively assessed by counting respiratory 
rates and using defined cut-off points, the use of this IMCI criterion results in high 
agreement between health center staff classification and pediatricians for identifying 
pneumonia. Chest indrawing was uncommon in the 3,438 children identified and was 
less frequently missed or mistakenly assigned than stridor or the two more 
subjectively assessed general danger signs of convulsions and ‘lethargic or 
unconscious’. The general danger signs are important for increasing the sensitivity of 
IMCI criteria to detect severe disease but they also lead to an over-classification of 
disease.  Their inclusion in the IMCI classification of severe disease needs to be 
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reviewed if these criteria are to be used in disease surveillance as well as for 
determine the impact of the IMCI strategy on specific illnesses. 
As children in Punial and Ishkoman were more likely to present with their 
mothers, who were probably better historians of illness than other caretakers. As 
children in Punial and Ishkoman were more likely to have acute illness and less likely 
to have co-morbidity, health center staff with the same level of experience and 
training may have found it less difficult to accurately classify sick children there than 
at the Gilgit DHQ Hospital.   
 An important limitation regarding the adjustment of incidence rates is that the 
disease classifications made by health center staff in Punial and Ishkoman were not 
compared against a reference standard, and were verifiable only by an internal 
consistency check based on IMCI criteria. Even if certain signs and symptoms were 
incorrectly identified by paramedical staff, an internally consistent and correct IMCI 
classification could still be made.  
While an attempt was made to select health center staff representative of 
those conducting surveillance in Punial and Ishkoman, there will be differences in 
training and experience between them that we can not account for completely. There 
were also differences in the level of supervision, with health center staff working on 
this study in Gilgit monitored on a daily basis whereas those in Punial and Ishkoman 
were visited once every two weeks. The presence of a pediatrician is likely to have 
resulted in quicker and perhaps more sustained skills development among health 
center staff at Gilgit than for staff that were relatively less frequently supervised in 
Punial and Ishkoman.  
Another potential limitation is that the cohort surveillance site in Punial and 
Ishkoman spans an altitude range between 5,500-9,499 feet whereas Gilgit town is 
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located between 4,500-5,499 feet. Although 51% of children enrolled in the Punial 
and Ishkoman cohort lived within an altitude of 5,500-6-499 feet, those residing at 
higher altitudes may have had higher baseline respiratory rates relative to children at 
lower altitudes, with the potential for over-classification of pneumonia based on fast 
breathing. 
If we assume that the rates of over and under-diagnosis are similar for health 
center staff throughout the study area, the results from this study can be used to 
adjust the estimated incidence rates of disease collected by similarly trained health 
center staff at first-level health facilities in Punial and Ishkoman. The adjustment in 
the incidence rate of pneumonia is minor because of the high degree of agreement 
between health center staff and pediatrician in using respiratory rate cut-offs for fast 
breathing. The adjustment in the incidence rate for severe pneumonia following 
adjustment is large, decreasing by almost half for children 2-35 months of age.  
Misclassification of disease by health workers using IMCI criteria can result 
in considerable overestimation of severe pneumonia and this should be taken into 
consideration when reporting incidence data. While this is an important safeguard 
within the IMCI strategy to identify and refer all children with severe disease, it is 
important to adjust for this misclassification when reporting incidence data in the 
Northern Areas. Similar studies in other programs will provide a useful assessment of 
the degree of misclassification in outcomes and may indicate a similar need for 





We would like to acknowledge the contributions of Ms. Himat Zareen and 
Mr. Akbar Khan and Dr. Mohammed Rafi, Dr. Agha Jan, Dr. Manzoor Khan of the 
Pediatrics Department of the Gilgit DHQ Hospital in screening children.  
 
 74
Table 10. Diagnostic classification for pneumonia and severe pneumonia based upon the World 
Health Organization Integrated Management of Childhood Illness (IMCI) strategy for children 
aged 2-59 months.  
  
 




Cough or difficulty breathing (by history) and fast breathing b  
 
 
Severe Pneumonia a 
 
Cough or difficulty breathing (by history) and chest indrawing 
or stridor or any general danger sign c  
 
 
a  Pneumonia and Severe Pneumonia are mutually exclusive classifications under 
IMCI 
b  ≥50 breaths per minute in a child 2-11 months old or ≥40 breaths per minute in a 
child 12-59 months old 
c Defined as the presence of any one or more of the following signs: 1) inability to 
breastfeed or swallow fluids; 2) persistent vomiting; 3) convulsions; and 4) 
unconscious or lethargic 
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Table 11. Characteristics of children (aged 2-35 months) with pneumonia or severe pneumonia, 








Parental History                                    n(%) or M (SD)    n(%) or M (SD)   
Mother is information provider 1,818 (58%) 97 (58%) 
Mean age of children in months  13.2 (8.6) 10.4 (8.4) 
Male sex of the child 1,986 (63%) 110 (66%) 
Antibiotic received within 7 days 
prior to visit 
1,132 (36%) 103 (62%) 
Co-trimoxazole 294 (9%) 12 (7%) 
Amoxicillin 674 (21%) 57 (34%) 
Others 206 (7%) 48 (29%) 
Child is able to breast feed or drink 3,145 118 (71%) 
Child vomits everything 0  47 (28%) 
Mean number of days - 5.2 (13.5) 
Child had convulsions 0 12 (7%) 
Mean number of days - 2.2 (1.9) 
Child has a cough 3,112 (99%) 165 (99%) 
Mean number of days 2.9 (2.5) 3.3 (2.8) 
Child has difficulty breathing 1,879 (60%) 108 (65%) 
Mean number of days 6.1 (7.9) 10.6 (16.4) 
Child has fever 3,105 (99%) 164 (98%) 
Mean number of days 5.1 (7.4) 6.6 (10.8) 
If fever >7 days, present every day 311 (10%) 35 (21%) 
Child has diarrhea 686 (22%) 35 (21%) 
Mean number of days 4.2 (9.6) 3.1 (6.0) 
Observation                                                n(%)                  n(%)            
Lethargic/Unconscious 0 40 (24%) 
Febrile > 37.5 C 515 (16%) 75 (45%) 
Fast breathing 3,145  162 (97%) 
Chest indrawing 0 143 (86%) 
Stridor 0 12 (7%) 
Stiff neck 0 2 (1%) 
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Table 12. Evaluation of 3,438 children aged 2-35 months who had cough or difficulty breathing and any one or more of fast breathing, chest indrawing, stridor or 
any general danger signs by health center staff and physician, Gilgit District Head Quarter Hospital, Northern Areas, Pakistan, November 2001-December 2002 
Pediatrician’s Clinical Evaluation  
 







 Pediatrician’s Clinical 
Diagnosis 






Health Center Staff Incorrectly 
Labeled Those That Do Not 

















173 (5.0%) 166 (4.8%) 157 (90.8%) 9 (5.4%) 16 (9.2%) 
Stridor 
 
29 (0.8%) 26 (0.8%) 18 (69.1%) 8 (30.8%) 11 (37.9%) 
Convulsions 
 




219 (6.4%) 99 (2.9%) 78 (78.8%) 21 (21.2%) 141 (64.4%) 
Pneumonia 
 














a Measured using pediatricians’ clinical evaluations as standard  b Percent of 3,438 children evaluated  c Percent of pediatrician evaluation or 
diagnosis  d Percent of health center staff evaluation or classification 
 
 77
Table 13. Proposed adjustment of incidence rates for pneumonia in Punial and Ishkoman based upon health center staff misclassification of pneumonia at the 
Gilgit DHQ Hospital, Northern Areas of Pakistan. November 2001-December 2002. 





















per 100 CYOc 
Adjusted 
Incidence Rate 
per 100 CYOc 
2-3 439 364 (83%)d 339 (77%)d 39 (11%)e 14 (4%)f 50.6 53.9 
4-5 455 418 (92%) 391 (86%) 31 (7%) 4 (1%) 67.5 71.8 
6-7 415 375 (90%) 350 (84%) 39 (10%) 14 (4%) 46.3 49.3 
8-9 292 264 (90%) 238 (82%) 34 (13%) 8 (3%) 38.5 42.2 
10-11 258 244 (95%) 223 (86%) 29 (12%) 8 (4%) 30 32.5 
12-13 280 266 (95%) 240 (86%) 31 (12%) 5 (2%) 30 32.9 
14-15 194 182 (94%) 162 (84%) 24 (13%) 4 (2%) 32.85 36.4 
16-17 176 165 (94%) 148 (84%) 20(12%) 3 (2%) 29.5 32.5 
18-19 170 158 (93%) 149 (88%) 14 (9%) 5 (3%) 23.85 25.2 
20-21 104 97 (93%) 93 (89%) 10 (10%) 6 (6%) 23.15 24.0 
22-23 154 146 (95%) 129 (84%) 17 (12%) 0 19.55 21.8 
24-25 183 173 (95%) 150 (82%) 27 (16%) 4 (3%) 17.05 19.3 
26-27 71 64 (90%) 53 (75%) 14 (22%) 3 (6%) 15 17.4 
28-29 64 60 (94%) 51 (80%) 9 (15%) 0  13.1 15.1 
30-31 73 66 (90%) 58 (79%) 9 (14%) 1 (2%) 7.4 8.3 
32-33 63 58 (92%) 48 (76%) 10 (17%) 0 5.55 6.5 
34-35 47 45 (96%) 42 (89%) 4 (9%) 1 (2%) 10.6 11.3 
All ages 3,438 3,145 (91%) 2,864 (83%) 361 (11%) 80 (3%) 29.9 32.5 
a 3,438 children from 32,213 screened who had cough or difficulty breathing with any of the following: fast breathing, stridor, chest indrawing or any general 
danger sign b Measured using pediatricians’ diagnosis as reference standard  c Child Years of Observation  d Percent of total children enrolled e Percent of 
pneumonia diagnosed by pediatricians  f Percent of pneumonia classified by health center staff
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Table 14. Proposed adjustment of incidence rates for severe pneumonia in Punial and Ishkoman based upon paramedical misclassification of severe pneumonia at 
the Gilgit DHQ Hospital, Northern Areas of Pakistan. November 2001-December 2002. 






















per 100 CYOc 
Adjusted 
Incidence Rate 
per 100 CYOc 
2-3 439 42 (10%)d 66 (15%)d 10 (24%)d 34 (52%)d 18.25 13.2 
4-5 455 23 (5%) 53 (12%) 0 30 (57%) 14.4 6.2 
6-7 415 29 (7%) 53 (13%) 8 (28%) 32 (60%) 10.95 7.4 
8-9 292 18 (6%) 46 (16%) 4 (22%) 32 (70%) 9.4 4.9 
10-11 258 5 (2%) 30 (12%) 3 (60%) 28 (93%) 7.6 5.1 
12-13 280 5 (2%) 31 (11%) 2 (40%) 28 (90%) 10 5.0 
14-15 194 7 (4%) 30 (15%) 1 (14%) 24 (80%) 6.05 2.1 
16-17 176 7 (4%) 24 (14%) 3 (43%) 20 (83%) 5.2 3.1 
18-19 170 5 (3%) 12 (7%) 3 (60%) 10 (83%) 8.4 6.4 
20-21 104 2 (2%) 10 (10%) 2 (100%) 10 (100%) 5.25 5.3 
22-23 154 3 (2%) 21 (14%) 0 18 (86%) 7.65 1.1 
24-25 183 6 (3%) 27 (15%) 3 (50%) 24 (89%) 3.9 2.4 
26-27 71 6 (3%) 14 (20%) 2 (33%) 10 (71%) 4.85 3.0 
28-29 64 2 (3%) 11 (17%) 0 9 (82%) 1.5 0.3 
30-31 73 4 (5%) 10 (14%) 1 (25%) 7 (70%) 2.6 1.4 
32-33 63 3 (5%) 13 (21%) 0 3 (23%) 0 NA 
34-35 47 0 2 (4%) 0 2 (100%) 0 NA 
All ages 3,438 167 (5%) 453 (13%) 42 (25%) 328 (72%) 8.1 4.3 
a 3,438 children from 32,213 screened who had cough or difficulty breathing with any of the following: fast breathing, stridor, chest indrawing 
or any general danger sign b Measured using pediatricians’ diagnosis as reference standard  c Child Years of Observation  d Percent of total 
children enrolled e Percent of pneumonia diagnosed by pediatricians  f Percent of pneumonia classified by health center staff
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The incidence rates for pneumonia and severe pneumonia were 29.9 and 8.1 per 
100 child years of observation (CYO), respectively. Younger age and altitude were 
associated with higher incidence rates of pneumonia and severe pneumonia. Further 
studies are needed to determine the etiology of the high burden of disease from 
pneumonia in these communities and consideration should be given to ‘probe’ trials using 
pneumococcal and Haemophilus influenzae type b conjugate vaccines. 
Sequential follow-up training of CHWs in the use of IMCI guidelines resulted in 
sustained improvements in test performance and disease referral over the course of 14 
months. Incorporating these training and evaluation methods should be considered for 
training of community health workers in all areas. Surveillance using less intensively 
trained CHWs is likely to lead to an underestimation of the true incidence of pneumonia. 
Health center staff trained in the use of IMCI criteria correctly classified the 
majority of children with signs or symptoms of pneumonia. However, misclassification 
of disease by health workers using IMCI criteria can result in considerable overestimation 







Future Research: the Case for Probe Trials in the Northern Areas of Pakistan 
The epidemiology of invasive Streptococcus pneumoniae (SPn) and Haemophilus 
influenzae type b (Hib)  disease reported in young Pakistani children with acute lower 
respiratory tract infections (ALRI) is unlike that seen in other countries, including 
neighboring India. Two studies conducted in the late 1980’s in Islamabad and Rawalpindi 
demonstrated an extremely high burden of invasive bacterial pneumonia. Ghafoor and 
colleagues isolated SPn from 132 (10%) and Haemophilus species from 144 (11%) of 
1,331 blood specimens collected from children under 5 of years of age in a mixed 
population of hospital inpatients and out-patients with ALRI.70 A higher than expected 
proportion of the Haemophilus isolates characterized were non-typeable Haemophilus 
influenzae (36%); the remaining (64%) were due to Hib.71 Mastro and colleagues 
enrolled 601 children 2-59 months old who presented with ALRI to two hospitals in 
Rawalpindi during a six month period between October 1989 and April 1990. 72 SPn was 
isolated from 108 (18%) and Haemophilus species from 100 (17%) blood culture 
specimens. Only 3 (3%) of the 89 Haemophilus isolates subsequently characterized were 
Hib, the remainder being non-typeable (92%) or other typeable (5%) Haemophilus 
influenzae. Blood cultures remain a highly specific but insensitive tool in ascertaining the 
etiology of community acquired bacterial pneumonia.73 Non-bacteremic pneumonia is a 
major disease worldwide but proving its etiology is even more difficult and costly.74  
Consideration must be given to ‘probe’ trials using SPn and Hib conjugate 
vaccines in the Northern Areas. Efforts are now underway to develop a site in Karachi for 
a potential pneumococcal conjugate vaccine trial possibly beginning in 2007 or 2008. In 
light of this new development in Karachi, the Northern Areas remains a strong candidate 
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site for the conduct of a Hib conjugate vaccine trial in Pakistan. Given the information 
available from Pakistan and the challenges of determining the etiologic agent in non-
bacteremic pneumonia, a well designed and properly conducted individually randomized 
trial to measure the efficacy of the Hib conjugate vaccine on the rates of radiologically 
defined pneumonia with lobar consolidation will add considerably to our understanding 
of Hib disease in Pakistan.  
The section that follows is a detailed literature review of the burden of Hib 
disease, the Hib conjugate vaccine and the results of Hib vaccine randomized control 
trials. Two key aspects of a Hib vaccine trial proposed for the Northern Areas of Pakistan 
are described in the appendix. The first is a statement of the study objectives and 
hypothesis. The second is the study design and methods, including a description of 
vaccine and control groups, outcome measures, eligibility criteria, selection of sites, unit 
of analysis, study power calculations, double blinding, enrollment procedures, and data 
analysis plan.  
 
Burden of Haemophilus Influenzae type b (Hib) Disease 
Haemophilus influenzae type b (Hib) infections are estimated to cause 3 million 
episodes of serious illness and between 400,000-700,000 deaths per year worldwide, the 
majority of which occur during the first two years of life.75 In an extensive review of the 
literature available from Asian countries, Peltola has estimated an average incidence of 
25 per 100,000 per year for Hib meningitis and of 40 per 100,000 per year for invasive 
Hib disease (including bacteremic pneumonia) in children less than 5 years old in Asia.76 
The incidence of the less-well described burden of non-bacteremic Hib pneumonia has 
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been conservatively estimated to be five-fold greater than that of the incidence of Hib 
meningitis around the world.77 
Controversy still surrounds the burden of Hib disease in some Asian countries.78,79 
The evidence cited against a high burden of childhood Hib disease in Asia is based upon 
studies from South and Southeast Asia that did not find Hib to be a common cause of 
meningitis or pneumonia among children admitted to hospital.80,81,82,83,84,85 A 1993 report 
from India found no Hib in 135 CSF cultures from children with meningitis.86 The 
incidence of Hib meningitis among children under 5 years of age in Hong Kong has been 
reported to be less than 2 per 100,000 per year, a figure substantially lower than the 
reported rate among the same age group in many industrialized nations in the pre-
vaccination era (e.g. 60 per 100,000 per year in the United States).11 The low estimates of 
invasive Hib disease in some Asian countries are believed to be attributable to a 
combination of poor reporting, indiscriminate use of antibiotics, infrequent use of blood 
and cerebro-spinal fluid (CSF) cultures, inadequate laboratory diagnosis, and the low 
rates of bacteremia in Hib pneumonia.2,87 A different explanation for these low disease 
incidence rates have been proposed by Puliyel et al.88 Based on reports of high levels of 
antibodies to Hib polyribosylribitol phosphate (anti-PRP) in young infants prior to 
vaccination, Puliyel raises the possibility that these may reflect cross-reactive antibodies 
to other common infections in early infancy that provide cross-protection against invasive 
Hib disease. This opinion conflicts with the results of a prospective, multi-center study 
conducted by the Invasive Bacterial Infections Surveillance (IBIS) Group in 6 Indian 
cities between 1993 and 1997 that found Hib to be the most frequent cause of bacterial 
meningitis in children less than 5 years of age.89 Almost 70% of all invasive Hib disease 
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identified and a quarter of all meningitis reported in children less than 5 years age 
occurred in infants, peaking between 6 to 9 months of age. 
 
Burden of Hib Disease in Pakistan 
Two studies conducted in the late 1980’s in Islamabad and Rawalpindi 
demonstrated a substantial burden of Haemophilus influenzae disease among children 
with acute lower respiratory tract infections (ALRI).90,91 Ghafoor and colleagues isolated 
Haemophilus species from 144 (11%) of 1,331 blood specimens collected from children 
under 5 of years of age in a mixed population of hospital inpatients and out-patients. 
(Table 15). A higher than expected proportion of the isolates characterized were non-
typeable Haemophilus influenzae (36%); the remaining (64%) were due to Hib.92 Mastro 
and colleagues enrolled 601 children 2-59 months old who presented with ALRI to two 
hospitals in Rawalpindi during a six month period between October 1989 and April 
1990.3 Haemophilus species were isolated from the blood of 100 (17%) children and only 
3 (3%) of the 89 isolates subsequently characterized were Hib, the remainder being non-
typeable (92%) or other typable (5%) Haemophilus influenzae. The large proportion of 
non-typeable Haemophilus influenzae is unlike that reported in other countries in the 
region where over 95% of the Haemophilus influenzae isolates from blood and CSF were 
type b, but  non-typeables exceeding 30% of all Haemophilus influenzae isolates have 
been reported in Papua New Guinea and The Gambia (Table 16).15,93,94 Qazi et al 
conducted a clinical trial during the early 1990s in Islamabad to measure the effect of 
dexamethasone therapy on children with suspected bacterial meningitis that showed 20 
(22%) of 89 patients had Haemophilus influenzae infection (capsular types not specified), 
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indicating that a considerable burden of meningitis was attributable to Haemophilus 
influenzae (regardless of the serotype).95   
 
Hib Conjugate Vaccines 
The pure polysaccharide Hib vaccines that became available in the 1970s afforded 
variable protection to children older than 18 months of age and were neither 
immunogenic nor efficacious in younger children.96 The capacity to mount protective 
immune responses to T cell-independent antigens is not usually developed until the 
second year of life, severely limiting the effectiveness of polysaccharide vaccines in 
controlling invasive Hib disease. The process of conjugating the polyribosylribitol 
phosphate (PRP) to a protein carrier, however, markedly improves the immunogenicity of 
the polysaccharide antigen in children less than 18 months, converting a T-cell 
independent immune response to a T-cell dependent one.97,98 Four such Hib conjugate 
vaccines have become available since the late 1980s, differing from each other primarily 
in the use of protein carriers, but also in the way the protein carrier is linked to the 
polysaccharide and the size of the polysaccharide molecule.99  
The first of these new Hib vaccines to become available was that of PRP 
conjugated to diphtheria toxoid (PRP-D). Both the efficacy and immunogenicity of this 
vaccine have been found to be less than optimal in some populations (Table 17), see 
following section) and it is currently not licensed for use in the primary series for infants 
in the US. Different vaccine companies also conjugated PRP to a modified diphtheria 
protein (PRP-CRM197, also known as HbOC), to outer membrane protein complex of 
group B meningococcus (PRP-OMP), and to tetanus toxoid (PRP-T). All three of these 
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conjugate vaccines have been licensed for use in the primary series for infants and are 
administered simultaneously with DTaP (2, 4 and 6 months) in the US. 
 
Hib Conjugate Vaccine Efficacy Trials in Industrialized Countries 
Four Hib conjugate vaccine efficacy trials were carried out in Finland and the US 
during the late 1980s and their results were published within a short span of seven 
months (Table 17). The first two trials (published simultaneously) were both of the 
polyribosylribitol phosphate-diphtheria toxoid (PRP-D) conjugate vaccine. The Finnish 
trial in 114,000 infants demonstrated an efficacy of 94% (95% Confidence Interval, 83-
98%) against invasive Hib disease, while the trial in 2,102 native Alaskan infants showed 
an efficacy of only 35% (95 CI, -57-73%).100,101 The results from a trial of Hib 
oligosaccharide conjugate vaccine (HbOC, also known as PRP-CRM197) in a 
heterogeneous population of 61,080 infants in California showed an efficacy of 100% 
(95% CI, 68-100%) against invasive Hib disease.102 A Hib polysaccharide-Neisseria 
meningitidis outer-membrane protein (PRP-OMP) conjugate trial in 5,190 Native 
American infants demonstrated 93% efficacy (95% CI, 53-98%) against invasive 
disease.103 A fifth trial conducted in the United Kingdom (published in 1994) enrolled 
27,708 children and showed an efficacy of 95% (95% CI, 74-100%).104 These initial trials 
laid the foundations for the inclusion of Hib conjugate vaccines in childhood 
immunization schedules in industrialized nations. 
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Impact of Hib Conjugate Vaccines in Industrialized Countries  
Wide scale use of the (Hib) conjugate vaccines has resulted in the virtual 
elimination of invasive Hib disease in industrialized countries during the 1990s.105,106 The 
annual incidence of Hib meningitis among children less than 5 years in the United States 
declined by 98% from between 50-60 per 100,000 to 1.6 following the licensure of the 
conjugate vaccine in 1991.107,108 There is a lack of epidemiological data available from 
developing countries that would be needed to determine the potential benefit and cost 
effectiveness of introducing these vaccines before national decisions can be made. 3,35,36 
 
Randomized Hib Conjugate Vaccine Trials in Developing Countries 
Randomized trials of conjugate Hib vaccines in The Gambia and Chile have 
demonstrated both a high efficacy against invasive Hib disease and a 20-25% reduction 
in the incidence of radiologically defined pneumonia among vaccine recipients, 
documenting the potential benefits of using Hib conjugate vaccines in developing 
countries (Table 17).109,110 
In a double blind, randomized trial in the Western Region of the Gambia, 
approximately 43,000 infants were randomly allocated to receive the Hib PRP-T 
conjugate vaccine mixed with DTP or DTP alone at 2,3, and 4 months of age. 
Surveillance for invasive Hib disease was conducted at three main hospitals in the region 
among children 5 to 36 months of age. Fifty cases of invasive Hib disease were detected 
over a three year period, 17 of which were culture-positive Hib pneumonia. The efficacy 
of the vaccine to prevent Hib pneumonia was 100% (95% Confidence Interval; 55, 100). 
The trial also demonstrated a 21% (95% CI; 4.6, 34.9) reduction in the cases of 
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radiologically defined pneumonia (showing definite radiological changes) and a 25% 
(95% CI; 0.24, 44.1) reduction in pneumonia with lobar consolidation. Hospital based 
surveillance data from the same sites prior to the vaccine trial had suggested that 10-15% 
of all pneumonias were due to Hib.111 The protection provided by the Hib conjugate 
vaccine at the same site during the vaccine trial suggests that the hospital based data 
substantially underestimated the true burden of Hib pneumonia in the population. 35 
In a randomized vaccine effectiveness trial in Santiago, Chile 36 of 71 
vaccination centers were randomly assigned to provide the Hib PRP-T vaccine. Children 
presenting to control vaccination centers were not offered the vaccine. In an analysis of 
approximately 20,000 children enrolled into the trial by Levine et al, 608 cases of 
pneumonia hospitalizations were detected among children 4-23 months of age.112 The 
incidence of pneumonia with radiologically defined consolidation or effusion was 
reduced by 22% (95% CI, -7 to 43) in the vaccine group. Both trials have documented 
potential benefits of the Hib conjugate vaccines and shown that its impact on pneumonia 
incidence in developing countries is likely to be many times greater than the impact on 
meningitis incidence. Mulholland, Levine and Peltola support the use of vaccine trials as 
‘probes’ for estimating the true burden of Hib pneumonia in populations where good 
quality data on Hib disease are lacking. 3,35,36 
While there is a growing body of evidence that invasive Hib disease is a 
significant burden of early childhood disease in several Asian countries, there are 
inconsistencies in studies. In a hamlet-randomized, controlled, double-blind vaccine-
probe study conducted by Gessner and colleagues in Lombok, Indonesia between 1998-
2002, 28,147 children were assigned to receive DTP-PRP-T and 26,926 received the 
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control DTP vaccine.113 The Hib vaccine in this setting showed no evidence of prevention 
of radiologically confirmed lobar pneumonia. 
There are many gaps in our knowledge and some unexpected observations that do 
not permit a conclusive statement regarding the burden of Hib disease in Pakistan. Many 
of the deficiencies are easily recognizable, such as the absence of surveillance systems 
for invasive Hib disease, the infrequent use of bacterial blood cultures in clinical practice 
and the inadequacy of laboratory methods utilized for Hib isolation at most centers in the 
country. The observations of the BOSTID studies in Islamabad and Rawalpindi on 
children with ALRI conducted were unusual with respect to the Haemophilus influenzae 
isolation rates from blood (11% and 17%), the proportion of Haemophilus influenzae 
isolated from blood that was not type b (34% and 92%) and the degree of clonal 
restriction among both type b and non-typeable isolates (two clonal types for Hib, nine 
for non-typeable Haemophilus influenzae).16,17,18 The available data would compel us to 
conclude that the epidemiology of invasive Haemophilus influenzae disease in Pakistani 
children is very different from what is observed in all other countries (including 
neighboring India) and that the benefits of Hib conjugate vaccines will be limited in 
Pakistan. 
An estimation of the potential benefits of preventing invasive Hib disease in 
Pakistan can not be made unless the evidence base is expanded.  Surveillance systems 
designed to detect invasive Hib disease in young children by strengthening case 
identification and laboratory methods in hospitals (such as IBIS in India) will continue to 
play a major role in our understanding of Hib disease in Asia. Some of the limitations of 
these surveillance systems include the difficulty in (1) enumerating the proportion of all 
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cases from the catchment population that access health facilities, (2) determining the 
implications of antibiotics received prior to a hospital visit on bacterial isolation rates and 
(3) standardizing laboratory methods across multiple centers. These challenges apply 
whether the surveillance is conducted out of a group of large urban hospitals or out of all 
small health centers accessible to a cohort being tracked in the community (although a 
community based cohort is more likely to yield a better estimate of the proportion of all 
cases that access health care).  
Blood cultures remain a highly specific but insensitive tool in ascertaining the 
etiology of community acquired pneumonia.114 Non-bacteremic pneumonia is a major 
disease worldwide but proving its etiology is more difficult and costly.3 While lung 
aspirates are a sensitive and specific method of determining the etiology of non-
bacteremic pneumonias they are performed infrequently and include greater risks to the 
patient than blood cultures. Lower respiratory tract secretions are difficult to obtain from 
younger children and are often contaminated by resident flora. Identification of 
organisms from nasopharyngeal swabs is not a good predictor of the organism involved 
in invasive disease and the sensitivity and specificity of serum antibodies to type b 





Table 15. Hospital and population based Haemophilus influenzae studies among Pakistani children, 1985-2001 
ALRI: acute lower respiratory tract infection, NP: nasopharyngeal, CSF: cerebrospinal fluid, RR: respiratory rate, NS: not specified;  1 Isolation and 
identification of the species were done in Pakistan, sero-typing and genotyping at the University of Washington. Losses were reported during 
transportation of specimens from Pakistan to the United States resulting in the variations in denominators reported.
Culture Results Site Date 
Published 
Group studied Number 
Studied
Case Definition 

















outpatients < 5 years
with ALRI 
1,492 Any one or more of the 
following: RR > 50/min; 
chest retractions; stridor; 
cyanosis; wheezing; rales 













Cough or difficulty breathing 
with one or more of the 
following: RR > 50/min; 
tachypnea; chest indrawing; 











































285 Healthy or  
with cough alone 






Islamabad  1996 Oct Inpatients with 
suspected bacterial 
meningitis 
2 months  - 12 years
103 Either of the two: 
CSF Gram stain +ve 
CSF Latex agglutination +ve 
And at least  two of the 
following: increased 
leucocytes cells; increased 
















Table 16. Serotypes of invasive H. influenzae isolates in cases of lower respiratory tract infections.  
(Adapted from Berman S. Epidemiology of Acute Respiratory Infections in Children of Developing Countries. Rev Inf Dis. 1991;13 
(Suppl 6):S454-S462) 
 
Percent of indicated serotype Site Source No. of 
strains Type b Non-type b Non-
typeable 
Papua New Guinea 
Shann F et al115 
Lung Aspirate 
Blood 
32 19% 25% 56% 
The Gambia 
Wall RA et al116 
Lung Aspirate 
Blood 
13 54% 15% 31% 
Blood 
 
95 64% 0 36% Pakistan 
Weinberg GA et al18 
 
Mastro TD et al17 
Blood 
 
89 3% 5% 92% 
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Table 17. Demonstrated efficacies of Haemophilus influenzae type b conjugate vaccines against invasive Hib disease, 1985-2002 
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J. Hib Probe Trial: Study Objectives and Hypothesis 
 
Objectives 
1. To estimate the efficacy of a Hib conjugate vaccine to reduce the incidence of 
pneumonia with lobar consolidation and all radiologically defined pneumonias in 
vaccinated children in comparison to a control group 
2. To determine the burden of community acquired pneumonia attributable to Hib among 





Ho: The difference in the rates of incidence of radiologically defined lobar pneumonia in 
the vaccine and control groups will be less than 15% 
 
Ha: There will a 15% or greater reduction in the incidence of radiologically defined lobar 
pneumonia between the vaccine and control groups 
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K. Hib Probe Trial: Study Design and Methods 
Description of Study Design 




Incidence of pneumonia with lobar consolidation; incidence of radiologically defined 
pneumonia.  
 
Description of Vaccine and Control Groups 
Children randomized to the vaccine group will be offered the licensed Hib PRP-T 
vaccine in addition to DTP vaccine at 6, 10 and 14 weeks. Children randomized to the 
control group will be offered a licensed meningococcal serogroup C polysaccharide-
protein conjugate vaccine in addition to DTP vaccine at 6, 10 and 14 weeks.  
 
Eligibility Criteria 
Infants between 6 to 12 weeks of age will be eligible for enrollment on their first visit to 
an EPI center at their scheduled DPT visit. The second and third doses will be scheduled 
4 and 8 weeks after the first dose. Children who are lagging in their immunization 





Infants will not be excluded if they have had a prior episode of disease that might have 
been caused by Hib. Infants who have previously received Hib vaccine, are immuno-
compromised (primary or acquired), or are on immunosuppressive therapy will not be 
eligible to participate in this trial. Laboratory screening for these disorders will not be 
performed; we will screen these conditions through a brief medical history at the time of 
enrollment. 
 
Unit of Analysis 
The unit of analysis will be a case with (1) pneumonia with lobar consolidation and (2) 




The 4-wheel drive vehicles organized by the LHB will be utilized by health staff at 
participating centers to refer all patients with severe pneumonia to a secondary or tertiary 
care facility with IV antibiotics and X-ray facilities. Every patient diagnosed with severe 
pneumonia will be offered free return transport at project cost to and from a center with 
an X-ray machine. The LHB will additionally be compensated if it is required to make 
alternative vehicle arrangements in medical emergencies while the primary vehicle is 
transporting a child with severe pneumonia. We expect to procure chest radiographs on 
80% of severe pneumonia cases presenting to participating health facilities. Chest 
radiographs will also be taken of all children who present with IMCI classified 




High levels of inter- and intra-observer agreement are preferred for the sake of diagnostic 
accuracy in chest radiographs when one or more radiologists are conducting the 
review.117 Pleural effusion and the presence of multi-lobar infiltrates have been shown to 
have acceptable inter-observer reliability.118 We will procure digital pictures of all 
radiographs using a camera focused on the radiograph set vertically on an illuminator. 
The digital images will be read by two independent radiologists, one in Gilgit and the 








                                                 
1 Greenberg SB. Viral Pneumonia. Infect Dis Clin North Am 1991;5:603 
2 Selwyn BJ. The epidemiology of acute respiratory tract infection in young children: 
Comparison of findings from several developing countries. Rev Infect Dis 
1990;12(Suppl.8):S870–88. 
3 Monto A. Studies of the community and family: acute respiratory illnesss and infection. 
Epidemiology Rev 1994;16:351 
4 Shann F. Etiology of severe pneumonia in children in developing countries. Pediatr 
Infect Dis J 1986;5(2); 247-252 
5 UNICEF. Child mortality statistics. http://www.childinfo.org/cmr/revis/db2.htm 
6 Bryce J, Boschi-Pinto C, Shibuya K, Black RE, and the WHO Child Health 
Epidemiology Reference Group. WHO estimates of the causes of death in children 
Lancet 2005; 365: 1147–52 
7 Black RE, Morris SS, Bryce J. Where and why are 10 million children dying every 
year? Lancet 2003; 36: 2226-2234 
8 Khan AJ, Khan JA, Akbar M, Addiss DG. Acute respiratory infections in children: a 
case management intervention in Abbottabad District, Pakistan. Bull World Health 
Organ. 1990;68(5):577-85. 
9 Marsh D, Majid N, Rasmussen Z, et al. Cause-specific child mortality in a mountainous 
community in Pakistan by verbal autopsy. J Pak Med Assoc 1993 Nov;43(11):226-9 
10 Aga Khan Health Service Pakistan. 2001 Annual Report, Northern Areas and Chitral 
Programme. 
11 Jalil F, Lindblad BS, Hanson LA et al. Early child health in Lahore, Pakistan : I. Study 
Design. Acta Paediatr 1993; 390 (Suppl): 3-16 
12 Zaman S, Jalil F, Karlberg J, Hanson LA. Early child health in Lahore, Pakistan : VI. 
Morbidity. Paediatr 1993; 390 (Suppl): 63-78 
13 Khan SR, Jalil F,  Zaman S, Lindblad BS, Karlberg J. Early child health in Lahore, 
Pakistan : X. Mortality. Paediatr 1993; 390 (Suppl): 109-17 
14 Ahmad I, Rasmussen ZA, Shaheen, Bulbulnissa. Epidemiology of WHO-defined 
Pneumonia in Children 2-59 Months, Oshikhandass, Northern Areas. The Aga Khan 
University Scientific Symposium, Karachi, Pakistan, 1996. 
15 Black RE, Brown K, Becker S. Longitudinal studies of infectious diseases and physical 
growth of children in rural Bangladesh. Am J Epidemiol 1982;115:305–14. 
16 James JW. Longitudinal study of the morbidity of diarrheal and respiratory infections 
in malnourished children. Am J Clin Nutr 1972;25:690–94. 
17 Barreto ML, Santos LM, Assis AM et al. Effect of vitamin A supplementation on 
diarrhoea and acute lower respiratory tract infections in young children in Brasil. Lancet 
1994;343:228–331. 
18 Black RE. Zinc deficiency, infectious disease and mortality in the developing world. J 
Nutr 2003;133(Suppl.1):1485S–89S. 
19 Oyejide CO, Osinusi K. Acute respiratory tract infection in children in Idikan 




                                                                                                                                                 
20 Mulholland K. Measles and pertussis in developing countries with good vaccine 
coverage. Lancet 1995;345:305–07. 
21 Tupasi TE, Leon LE, Lupisan S et al. Patterns of acute respiratory tract infection in 
children: A longitudinal study in a depressed community in Metro Manila. Rev Infect Dis 
1990;12:S940–49.  
22 Ruutu P, Halonen P, Meurman O et al. Viral lower respiratory tract infections in 
Filipino children. J Infect Dis 1990;161:175–79. 
23 Victora CG, Kirkwood BR, Ashworth A et al. Potential interventions for the prevention 
of childhood pneumonia in developing countries: improving nutrition. Am J Clin Nutr 
1999;70:309–20. 
24 Lopez de Romana G, Brown KH, Black RE, Kanashiro HC. Longitudinal studies of 
infectious diseases and physical growth of infants in Huascar, an underprivileged peri-
urban community in Lima, Peru. Am J Epidemiol 1989;129:769–84. 
25 Smith KR, Samet JM, Romieu I, Bruce N. Indoor air pollution in developing countries 
and acute lower respiratory infections in children. Thorax 2000;55:518–32. 
26 Armstrong J, Campbell H. Indoor air pollution exposure and lower respiratory 
infections in young Gambian children. Int J Epidemiol 1991;20:424–29. 
27 Rudan I, Tomaskovic L, Boschi-Pinto C, Campbell H; WHO Child Health 
Epidemiology Reference Group. Global estimate of the incidence of clinical pneumonia 
among children under five years of age. Bull World Health Organ. 2004 Dec;82(12):895-
903. 
28 Lanata CF, Quintanilla N, Verastegui HA. Validity of a respiratory questionnaire to 
identify pneumonia in children in Lima, Peru. Int J Epidemiol 1994;23:827–34. 
29 Lehmann, D. 1992. Epidemiology of acute respiratory tract infections, especially 
those due to Haemophilus influenzae, in Papua New Guinean children. 
J. Infect. Dis. 165:S20–S25. 
30 Schoene RB, Hornbein TF. High altitude adaptation In: Nadel J, Murray J, eds. 
Textbook of respiratory medicine. Philadelphia: WB Saunders, 1987: 196-220 
31 Proceedings of the Pakistan Pediatric Association Conference, April 2002. 
Recommendation of the IMCI Working Group. 
32 Department Of Child And Adolescent Health And Development, World Health 
Organization. IMCI Planning Guide: Gaining experience with the IMCI strategy in a 
Country. WHO/CHS/CAH/99.1 
33 Rowe AK, Hirnschall G, Lambrechts T, Bryce J. Linking the Integrated Management 
of Childhood Illness (IMCI) and health information system (HIS) classifications: issues 
and options. WHO Bulletin 1999; 77(12): 988-995 
34 Lambrechts T, Bryce J, Orinda V. Integrated Management of Childhood Illness: 
a summary of first experiences. WHO Bulletin 1999; 77(7): 582-594 
35 Aga Khan Health Service Pakistan. 2000 Annual Report, Northern Areas and Chitral 
Programme. 
36 Pakistan Demographic Health Survey 1998. 
37 Black RE, Morris SS, Bryce J. Child survival I: Where and why are 10 million children dying 
every year? Lancet 2003; 361: 2226-34 
38 Khan AJ, Khan JA, Akbar M, Addiss DG. Acute respiratory infections in children: a case 




                                                                                                                                                 
39 Marsh D, Majid N, Rasmussen Z, et al. Cause-specific child mortality in a mountainous 
community in Pakistan by verbal autopsy. J Pak Med Assoc 1993 Nov;43(11):226-9 
40 2001 Annual Report. Aga Khan Health Service, Pakistan Northern Areas and Chitral 
Programme. 
41 Jalil F, Lindblad BS, Hanson LA et al. Early child health in Lahore, Pakistan : I. Study Design. 
Acta Paediatr 1993; 390 (Suppl): 3-16 
42 Zaman S, Jalil F, Karlberg J, Hanson LA. Early child health in Lahore, Pakistan : VI. Morbidity. 
Paediatr 1993; 390 (Suppl): 63-78 
43 Khan SR, Jalil F,  Zaman S, Lindblad BS, Karlberg J. Early child health in Lahore, Pakistan : X. 
Mortality. Paediatr 1993; 390 (Suppl): 109-17 
44 Pechere JC. Editor. Community Acquired Pneumonia in Children, 1995. 
45 Shann F. Etiology of severe pneumonia in children in developing countries. Pediatr 
Infect Dis J 1986;5(2); 247-252 
46 Berman S. Epidemiology of Acute Respiratory Infections in Developing  Countries. Reviews 
Infect Dis. 1991;13(Suppl 6): S454-62 
47 Fatmi Z, White F. A comparison of ‘cough and cold’ and pneumonia: risk factors for 
pneumonia in children under 5 years revisited. 
48 Proceedings of the PPA meeting April 2002, p?? 
49 2001 Annual Report. Aga Khan Health Service Pakistan, Northern Areas Programme.  
50 An Evaluation of the Aga Khan Development Network in the Northern Areas of Pakistan. 
External Review. 1998 (Hugh Annet reference) 
51 AKHSP uses the national schedule for EPI in which newborns receive OPV and BCG at birth 
followed by OPV and DPT administered at 6, 10, and 14 weeks and measles at 9 months of age. In 
2002, hepatitis B vaccine was added to the national EPI program but its availability has been very 
variable. 
52 Manuscript under preparation. Waters H, Hussain H, Khan A et al. 
53 Heffelfinger J, Davis TE , Gebrian B. Evaluation of children with recurrent 
pneumonia diagnosed by World Health Organization criteria. Pediatr Infect Dis J, 
2002;21:108–12 
54IMCI Working Group. Review of IMCI in Pakistan. Proceedings of the Pakistan Pediatric 
Association, April 2002. 
55 2001 Annual Report. Aga Khan Health Service Pakistan, Northern Areas Programme.  
56 An Evaluation of the Aga Khan Development Network in the Northern Areas of Pakistan. 
External Review. 1998 
57 AKHSP uses the national schedule for EPI in which newborns receive OPV and BCG at birth 
followed by OPV and DPT administered at 6, 10, and 14 weeks and measles at 9 months of age. In 
2002, hepatitis B vaccine was added to the national EPI program but its availability has been very 
variable. 
58 Khan AJ, Hussain HF, Omer S, et al. Incidence and Associated Risk Factors for Pneumonia 
among Children 2-35 Months of Age Living at High Altitudes in Pakistan. 2005, unpublished. 
59 Peter Winch JHU report 
60 For scanned copies of the Urdu form, contact corresponding author. 
61 Primary Health Care Cell, Ministry of Health, World Health Organization, UNICEF. Integrated 
Management of Childhood Illness: Assessment, Classification, Treatment, Referral, Counselling, 
Follow-up. WHO/PAK/00-2.A-G 
62 IMCI Working Group. Review of IMCI in Pakistan. Proceedings of the Pakistan Pediatric 
Association, April 2002.  
63 Arifeen SE, Blum LS, Hoque DME, et al. Integrated Management of Childhood Illness (IMCI) 
in 
Bangladesh: early findings from a cluster-randomised study. Lancet 2004; 364: 1595–602 
 
 118
                                                                                                                                                 
64 Amaral J, Gouws E, Bryce J, et al. Cad. Saúde Pública, Rio de Janeiro, 20 Sup 2:S209-S219, 2004 
65 Odhacha A, Orone H, Pambala, M, et al. Health worker performance after training in 
Integrated Management of Childhood Illness--Western Province, Kenya, 1996-1997. MMWR: 
Morbidity & Mortality Weekly Report; 11/27/98, Vol. 47 Issue 46, p998, 4p 
66 Gove S., WHO Working Group on Guidelines for Integrated Management of the Sick Child. 
Integrated management of childhood illness by outpatient health workers: technical basis and 
overview. WHO Bulletin 1997, 75 (S1) 7-24 
67 Weber MW, Mulholland EK, Jaffar S, et al. Evaluation of an algorithm for the integrated 
management of childhood illness in an area with seasonal malaria in the Gambia. WHO Bulletin,  
1997, 75 (S 1) 25-32 
68 WHO Division of Child Heath and Development & WHO Regional Office for Africa. Integrated 
management of childhood illness: field test of the WHO/UNICEF training course in Arusha, 
United Republic of Tanzania. WHO Bulletin, 1997, 7 (S1) 55-64 
69 2001 Annual Report. Aga Khan Health Service Pakistan, Northern Areas Programme.  
70 Ghafoor A, Nomani NK, Ishaq Z, et al. Diagnoses of Acute Lower Respiratory Tract Infections 
in Children in Rawalpindi and Islamabad, Pakistan. Rev Infect Dis 1990; 12 (Suppl 8); S907-S914 
[Supported by the Board of Science and Technology for International Development (BOSTID)] 
71 Weinberg GA, Ghafoor A, Ishaq Z, et al. Clonal Analysis of Haemophilus influenzae Isolated 
from Children from Pakistan with Lower Respiratory Tract Infections. J Infect Dis 1989; Vol 160 
(4): 634-43 [Supported by the Board of Science and Technology for International Development 
(BOSTID)] 
72 Mastro TD, Nomani NK, Ghafoor A, et al. Use of nasopharyngeal isolates of Streptococcus 
pneumonia and Haemophilus influenzae from children in Pakistan for surveillance for 
antimicrobial resistance. Pediatr Infect Dis J 1993; 12: 824-30 [Supported by the Board of Science 
and Technology for International Development (BOSTID)] 
73 Isaacs D. Problems in determining the etiology of community-acquired pneumonia. Pediatr 
Infect Dis J 1989; 8: 143-48 
74 Peltola H. Worldwide Haemophilus influenzae type b disease at the beginning of the 21st 
century: Global analysis of the disease burden 25 years after the use of polysaccharide vaccines 
and a decade after the advent of conjugates. Clin Micro Reviews 2000; 13 (2): 302-17 
75 World Health Organization. Global program for vaccines and immunization. The WHO 
position paper on Haemophilus influenzae type b conjugate vaccines. Wkly. Epidemiolo. Rec. 
1998; 73: 64-68 
76 Peltola H. Spectrum and burden of severe Haemophilus influenzae type b diseases in Asia. 
Bulletin WHO 1999; 77 (11): 878-887 
77 Peltola H. Worldwide Haemophilus influenzae type b disease at the beginning of the 21st 
century: Global analysis of the disease burden 25 years after the use of polysaccharide vaccines 
and a decade after the advent of conjugates. Clin Micro Reviews 2000; 13 (2): 302-17 
78 Lau YL Editorials. Haemophilus influenzae type b diseases in Asia. Bulletin WHO 1999; 77 (11): 
867-868 
79 Lee JW. Haemophilus influenzae in Asia. Pediatr Infect Dis J 1998; 17: S92-S93 
80 Sirinavin S. Regional epidemiology of invasive Haemophilus influenzae type b disease. JAMA 
SEA 1993;9(Suppl):11-15.   
81 Deivanayagam N, Ashok TP, Neduchelian K, Ahmed SS, Mala N. Bacterial meningitis: 
diagnosis by latex agglutination test and clinical features. Indian Pediatr 1993; 30:495-500 
82 Kabra SK, Kumar P, Verma IC, et al. Bacterial Meninigitis in India: an IJP survey. Indian J 
Pediatr 1991: 8: 505-11 
 
 119
                                                                                                                                                 
83 Sung RYT. Meningitis in Hong Kong children, with special reference to the infrequency of 
Haemophilus and meningococcal infection. J Paediatr Child Health 1997; 33: 296-299 
84 Lau YL. Invasive Haemophilus influenzae type b infections in children hospitalized in Hong 
Kong, 1986-1990. Acta paediatrica 1995; 84: 173-176 
85 Lau YL. Haemophilus influenzae type b infections in Hong Kong. Pediatric infectious diseases 
1998; 12: S165-S169 
86 Panjarathinam R, Shah RK. Pyogenic meningitis in Ahmedabad. Indian J Pediatr 1993; 60: 669-
73 
87 Invasive Haemophilus influenzae disease in India: a preliminary report of prospective multi-
hospital  
88 Puliyel JM, Agarwal KS, Abass FA. Natural immunity to Haemophilus influenza b in infancy in 
Indian children. Vaccine 2001; 19:  4592-4594 
89 Invasive Bacterial Infections Surveillance  (IBIS) Group. Are Haemophilus influenzae infections 
a significant problem in India? A prospective study and review. Clin Infect Dis 2002; 34: 949-57 
90 Ghafoor A, Nomani NK, Ishaq Z, et al. Diagnoses of Acute Lower Respiratory Tract Infections 
in Children in Rawalpindi and Islamabad, Pakistan. Rev Infect Dis 1990; 12 (Suppl 8); S907-S914 
[Supported by the Board of Science and Technology for International Development (BOSTID)] 
91 Mastro TD, Nomani NK, Ghafoor A, et al. Use of nasopharyngeal isolates of Streptococcus 
pneumonia and Haemophilus influenzae from children in Pakistan for surveillance for 
antimicrobial resistance. Pediatr Infect Dis J 1993; 12: 824-30 [Supported by the Board of Science 
and Technology for International Development (BOSTID)] 
92 Weinberg GA, Ghafoor A, Ishaq Z, et al. Clonal Analysis of Haemophilus influenzae Isolated 
from Children from Pakistan with Lower Respiratory Tract Infections. J Infect Dis 1989; Vol 160 
(4): 634-43 [Supported by the Board of Science and Technology for International Development 
(BOSTID)] 
93 Saha SK, Rikitomi N, Ruhulamin M, et al. The increasing burden of disease in Bangladeshi 
children due to Haemophilus influenzae type b meningitis. Ann Trop Paediatr 1997; 17: 5-8 
94 Berman S.  Epidemiology of Acute Respiratory Infections in Children of Developing Countries. 
Rev Inf Dis 1991; 13 (Suppl 6): S454-S462 
95 Qazi SA, Khan MA, Mughal N, et al. Dexamethosone and bacterial meningitis in Pakistan. Arch 
Dis Childhood 1996; 75: 482-488 
96 Peltola H, Käyhty H, Sivonen A, Mäkelä PH. Haemophilus influenzae type b capsular 
polysaccharide vaccine in children: a double-blind field study of 100 000 vaccinees 3 months to 5 
years of age in Finland. Pediatrics 1977; 60: 730-7.   
97 Käyhty H, Eskola J, Peltola H, et al. Antibody responses to four Haemophilus influenzae type b 
conjugate vaccines. Am J Dis Child 1991; 145: 223-7. 
98 Mulholland EK, Ahonkhai VI, Greenwood AM, et al. Safety and immunogenicity of 
Haemophilus influenzae type B-Neisseria meningitidis group B outer membrane protein complex 
conjugate vaccine mixed in the syringe with diphtheria-tetanus-pertussis vaccine in young 
Gambian infants. Pediatr Infect Dis J 1993; 12: 632-7.   
99 Levine OS, Schwartz B, Piecre N, Kane M. Development, evaluation and implementation of 
Haemophilus influenzae type b vaccines for young children in developing countries: current 
status and priority actions.  Pediatr Infect Dis J 1998; 17: S95-S113 
100 Eskola J, Kayhty H, Takala AK, et al. A randomized, prospective field trial of a conjugate 
vaccine in the protection of infants and young children against invasive Haemophilus influenzae 
type b disease. NEJM 1990; 323: 1381-1387 
101 Ward J, Brenneman G, Letson GW, et al. Limited efficacy of a Haemophilus influenzae type b 
conjugate vaccine in Alaska native infants. NEJM 1990 ; 323 : 1393-1401  
102 Black SB, Shinefield HR, Fireman B, et al. Efficacy in infancy of oligosaccharide conjugate 
Haemophilus influenzae type b (HbOC) vaccine in a United States population of 61,080 children. 
Pediatr Infect Dis J 1991; 10: 97-104 
 
 120
                                                                                                                                                 
103 Santosham M, Wolff M, Reid R, et al. The efficacy in Navajo infants of a conjugate vaccine 
consisting of Haemophilus influenzae type b polysaccharide and Neisseria meningitidis outer-
membrane protein complex. NEJM; 324; 25: 1767-1772 
104 Booy R, Hodgson S, Carpenter L, et al. Efficacy of Haemophilus influenzae type b conjugate 
vaccine PRP-T. Lancet 1994; 344: 362-6. 
105 Adams WG, Deaver KA, Cochi SL, et al. Decline of childhood Haemophilus influenzae type b 
(Hib) disease in the Hib vaccine era. JAMA 1993; 269: 221-26 
106 Peltola H, Kilpi T, and Anttial M. Rapid disappearance of Haemophilus influenzae type b 
meningitis after routine childhood immunization with conjugate vaccines. Lancet 1992; 340: 592-
94 
107 Bisgard KM, Kao A, Leake J, et al. Haemophilus influenzae invasive disease in the United 
States, 1994-1995: Near disappearance of a vaccine-preventable childhood disease. Emerg Infect 
Dis 1998; 4: 229-37 
108 CDC. Progress toward elimination of Haemophilus influenzae type b disease among infants 
and children – United States, 1987-1997. MMWR 1998; 47: 993-8 
109 Mulholland K, Hilton S, Adegbloa R, et al. Randomized trial of Haemophilus influenzae type-b 
tetanus protein conjugate for prevention of pneumonia and meningitis in Gambian infants. 
Lancet 1997; 349: 1191-97 
110 Levine OS, Lagos R, Munoz A et al. Defining the burden of pneumonia in children preventable 
by vaccination against Haemophilus influenzae type b. Ped Inf Dis J 1999 ; 18 : 1060-64 
111 Greenwood BM. Epidemiology of acute lower respiratory tract infections, especially those due 
Haemophilus influenzae type b, in The Gambia, West Africa. J Infect Dis 1992; 165: S26-28 
112 Levine OS, Lagos R, Munoz A, et al. Defining the burden of pneumonia in children 
preventable by vaccination against Haemophilus influenzae type b. Pediatr Infect Dis J 199: 18: 
1060-64 
113 Gessner BD, Sutanto A, Linehan M, et al. Incidences of vaccine-preventable Haemophilus 
influenzae type b pneumonia and meningitis in Indonesian children: hamlet-randomised 
vaccine-probe trial. Lancet. 2005 Jan 1-7;365(9453):43-52. 
114 Isaacs D. Problems in determining the etiology of community-acquired pneumonia. Pediatr 
Infect Dis J 1989; 8: 143-48 
115 Shann F, Graaten M, Germer S, Linneamann V, Hazlett D, Payne R. Aetiology of pneumonia in 
children in Goroka Hospital, Papua New Guinea. Lancet 1984; 2: 537-41 
116 Wall RA, Corrah PT, Mabey DCW, Greenwood BM. The etiology of lobar pneumonia in the 
Gambia. Bull World Health Organ 1986;  64: 553-8 
117 Swingler GH. Observer variation in chest radiography of acute lower respiratory infections in 
children: a systematic review. BMC Medical Imaging 2001; 1:1 
118 Albaum MN, Hill LC, Murphy M et al. Interobserver Reliability of the Chest Radiograph in 
Community-Acquired Pneumonia. Chest 1996; 110(2): 343-350 
 121
Curriculum Vita 
Aamir Javed Khan was born in Lahore, Pakistan on June 7, 1969. He is a graduate of the 
Aga Khan University Medical School and has worked there as a Research Officer in 
Epidemiology. Aamir joined the faculty at Johns Hopkins as a Research Associate in 
1998, where he now has a part-time faculty appointment. While based out of Johns 
Hopkins, Aamir coordinated research on persistent excretion of poliovirus in 7 countries, 
including Pakistan. His current work with Johns Hopkins includes serving as the Co-
Principal Investigator on the GAVI PneumoADIP Asian Field Site Development grant 
for urban Karachi and a Co-Investigator on the Karachi measles surveillance project. 
 
Aamir is the Director of Interactive R&D, a contract research organization (CRO) based 
in Karachi. This CRO was established in March 2004 and conducts work in the areas of 
epidemiology, clinical trials and geographical information systems. The company 
currently employs 44 full-time staff members. 
 
 
